| Gene Ontology term | Cluster frequency | Protein frequency of use | P-value |
|---|
| muscle cell development | 5 out of 47 genes, 10.6% | 5 out of 533 genes, 0.9% | 4.360381e-06 |
| striated muscle cell development | 5 out of 47 genes, 10.6% | 5 out of 533 genes, 0.9% | 4.360381e-06 |
| muscle organ development | 5 out of 47 genes, 10.6% | 6 out of 533 genes, 1.1% | 2.442804e-05 |
| cellular component organization | 28 out of 47 genes, 59.6% | 169 out of 533 genes, 31.7% | 3.39067e-05 |
| myofibril assembly | 4 out of 47 genes, 8.5% | 4 out of 533 genes, 0.8% | 5.364283e-05 |
| actomyosin structure organization | 4 out of 47 genes, 8.5% | 4 out of 533 genes, 0.8% | 5.364283e-05 |
| actin-myosin filament sliding | 4 out of 47 genes, 8.5% | 4 out of 533 genes, 0.8% | 5.364283e-05 |
| actin-mediated cell contraction | 4 out of 47 genes, 8.5% | 4 out of 533 genes, 0.8% | 5.364283e-05 |
| striated muscle cell differentiation | 5 out of 47 genes, 10.6% | 7 out of 533 genes, 1.3% | 7.983307e-05 |
| muscle structure development | 6 out of 47 genes, 12.8% | 11 out of 533 genes, 2.1% | 0.0001134708 |
| cellular component organization or biogenesis | 28 out of 47 genes, 59.6% | 180 out of 533 genes, 33.8% | 0.000131988 |
| single-organism process | 41 out of 47 genes, 87.2% | 341 out of 533 genes, 64.0% | 0.0002037586 |
| muscle system process | 4 out of 47 genes, 8.5% | 5 out of 533 genes, 0.9% | 0.0002507726 |
| muscle contraction | 4 out of 47 genes, 8.5% | 5 out of 533 genes, 0.9% | 0.0002507726 |
| striated muscle tissue development | 4 out of 47 genes, 8.5% | 5 out of 533 genes, 0.9% | 0.0002507726 |
| muscle tissue development | 4 out of 47 genes, 8.5% | 5 out of 533 genes, 0.9% | 0.0002507726 |
| cellular component movement | 10 out of 47 genes, 21.3% | 35 out of 533 genes, 6.6% | 0.0003763179 |
| muscle cell differentiation | 5 out of 47 genes, 10.6% | 9 out of 533 genes, 1.7% | 0.0004176675 |
| actin filament-based process | 7 out of 47 genes, 14.9% | 19 out of 533 genes, 3.6% | 0.0005937618 |
| muscle filament sliding | 3 out of 47 genes, 6.4% | 3 out of 533 genes, 0.6% | 0.0006461522 |
| muscle organ morphogenesis | 3 out of 47 genes, 6.4% | 3 out of 533 genes, 0.6% | 0.0006461522 |
| cardiac muscle tissue development | 3 out of 47 genes, 6.4% | 3 out of 533 genes, 0.6% | 0.0006461522 |
| skeletal muscle fiber development | 3 out of 47 genes, 6.4% | 3 out of 533 genes, 0.6% | 0.0006461522 |
| muscle fiber development | 3 out of 47 genes, 6.4% | 3 out of 533 genes, 0.6% | 0.0006461522 |
| cardiac muscle tissue morphogenesis | 3 out of 47 genes, 6.4% | 3 out of 533 genes, 0.6% | 0.0006461522 |
| muscle tissue morphogenesis | 3 out of 47 genes, 6.4% | 3 out of 533 genes, 0.6% | 0.0006461522 |
| actin filament-based movement | 4 out of 47 genes, 8.5% | 6 out of 533 genes, 1.1% | 0.0007034617 |
| actin cytoskeleton organization | 6 out of 47 genes, 12.8% | 15 out of 533 genes, 2.8% | 0.0009326113 |
| extracellular matrix organization | 5 out of 47 genes, 10.6% | 11 out of 533 genes, 2.1% | 0.00133557 |
| extracellular structure organization | 5 out of 47 genes, 10.6% | 11 out of 533 genes, 2.1% | 0.00133557 |
| cellular component assembly involved in morphogenesis | 4 out of 47 genes, 8.5% | 7 out of 533 genes, 1.3% | 0.001534967 |
| locomotion | 8 out of 47 genes, 17.0% | 28 out of 533 genes, 5.3% | 0.001610819 |
| cell development | 8 out of 47 genes, 17.0% | 29 out of 533 genes, 5.4% | 0.002075591 |
| heart morphogenesis | 3 out of 47 genes, 6.4% | 4 out of 533 genes, 0.8% | 0.00242368 |
| circulatory system process | 3 out of 47 genes, 6.4% | 4 out of 533 genes, 0.8% | 0.00242368 |
| heart process | 3 out of 47 genes, 6.4% | 4 out of 533 genes, 0.8% | 0.00242368 |
| skeletal muscle tissue development | 3 out of 47 genes, 6.4% | 4 out of 533 genes, 0.8% | 0.00242368 |
| blood circulation | 3 out of 47 genes, 6.4% | 4 out of 533 genes, 0.8% | 0.00242368 |
| innate immune response | 3 out of 47 genes, 6.4% | 4 out of 533 genes, 0.8% | 0.00242368 |
| heart contraction | 3 out of 47 genes, 6.4% | 4 out of 533 genes, 0.8% | 0.00242368 |
| skeletal muscle organ development | 3 out of 47 genes, 6.4% | 4 out of 533 genes, 0.8% | 0.00242368 |
| cellular component morphogenesis | 7 out of 47 genes, 14.9% | 25 out of 533 genes, 4.7% | 0.003738128 |
| single-organism cellular process | 37 out of 47 genes, 78.7% | 320 out of 533 genes, 60.0% | 0.003879026 |
| regulation of biological quality | 13 out of 47 genes, 27.7% | 71 out of 533 genes, 13.3% | 0.004770976 |
| leukocyte mediated immunity | 3 out of 47 genes, 6.4% | 5 out of 533 genes, 0.9% | 0.005683042 |
| regulation of muscle contraction | 3 out of 47 genes, 6.4% | 5 out of 533 genes, 0.9% | 0.005683042 |
| actin filament organization | 3 out of 47 genes, 6.4% | 5 out of 533 genes, 0.9% | 0.005683042 |
| cytoskeleton organization | 7 out of 47 genes, 14.9% | 28 out of 533 genes, 5.3% | 0.00747857 |
| immune response | 4 out of 47 genes, 8.5% | 10 out of 533 genes, 1.9% | 0.007536496 |
| cell killing | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| leukocyte mediated cytotoxicity | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| natural killer cell mediated immunity | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| striated muscle contraction | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| regulation of blood pressure | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| skeletal myofibril assembly | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| skeletal muscle thin filament assembly | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| cardiocyte differentiation | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| natural killer cell mediated cytotoxicity | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| sarcomere organization | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| cardiac myofibril assembly | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| cardiac cell development | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| cardiac muscle cell differentiation | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| cardiac muscle cell development | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| cardiac muscle contraction | 2 out of 47 genes, 4.3% | 2 out of 533 genes, 0.4% | 0.007624596 |
| regulation of muscle system process | 3 out of 47 genes, 6.4% | 6 out of 533 genes, 1.1% | 0.01066262 |
| chemotaxis | 5 out of 47 genes, 10.6% | 17 out of 533 genes, 3.2% | 0.0118792 |
| taxis | 5 out of 47 genes, 10.6% | 17 out of 533 genes, 3.2% | 0.0118792 |
| response to external stimulus | 6 out of 47 genes, 12.8% | 24 out of 533 genes, 4.5% | 0.01348069 |
| organelle organization | 13 out of 47 genes, 27.7% | 80 out of 533 genes, 15.0% | 0.01399688 |
| macromolecular complex subunit organization | 13 out of 47 genes, 27.7% | 82 out of 533 genes, 15.4% | 0.01726986 |
| immune effector process | 3 out of 47 genes, 6.4% | 7 out of 533 genes, 1.3% | 0.01750836 |
| lymphocyte mediated immunity | 2 out of 47 genes, 4.3% | 3 out of 533 genes, 0.6% | 0.02158148 |
| regulation of heart contraction | 2 out of 47 genes, 4.3% | 3 out of 533 genes, 0.6% | 0.02158148 |
| response to temperature stimulus | 2 out of 47 genes, 4.3% | 3 out of 533 genes, 0.6% | 0.02158148 |
| response to heat | 2 out of 47 genes, 4.3% | 3 out of 533 genes, 0.6% | 0.02158148 |
| fertilization | 2 out of 47 genes, 4.3% | 3 out of 533 genes, 0.6% | 0.02158148 |
| cell projection organization | 6 out of 47 genes, 12.8% | 27 out of 533 genes, 5.1% | 0.02411579 |
| system process | 5 out of 47 genes, 10.6% | 20 out of 533 genes, 3.8% | 0.02427459 |
| anatomical structure formation involved in morphogenesis | 5 out of 47 genes, 10.6% | 20 out of 533 genes, 3.8% | 0.02427459 |
| system development | 9 out of 47 genes, 19.1% | 51 out of 533 genes, 9.6% | 0.02584995 |
| axon guidance | 4 out of 47 genes, 8.5% | 14 out of 533 genes, 2.6% | 0.02754167 |
| cardiovascular system development | 4 out of 47 genes, 8.5% | 14 out of 533 genes, 2.6% | 0.02754167 |
| circulatory system development | 4 out of 47 genes, 8.5% | 14 out of 533 genes, 2.6% | 0.02754167 |
| response to abiotic stimulus | 5 out of 47 genes, 10.6% | 21 out of 533 genes, 3.9% | 0.02977187 |
| protein complex subunit organization | 10 out of 47 genes, 21.3% | 61 out of 533 genes, 11.4% | 0.03066206 |
| wound healing | 4 out of 47 genes, 8.5% | 15 out of 533 genes, 2.8% | 0.03515455 |
| regulation of system process | 4 out of 47 genes, 8.5% | 15 out of 533 genes, 2.8% | 0.03515455 |
| neuron differentiation | 5 out of 47 genes, 10.6% | 22 out of 533 genes, 4.1% | 0.03600557 |
| cation transport | 3 out of 47 genes, 6.4% | 9 out of 533 genes, 1.7% | 0.03701908 |
| heart development | 3 out of 47 genes, 6.4% | 9 out of 533 genes, 1.7% | 0.03701908 |
| tissue morphogenesis | 3 out of 47 genes, 6.4% | 9 out of 533 genes, 1.7% | 0.03701908 |
| homeostatic process | 6 out of 47 genes, 12.8% | 30 out of 533 genes, 5.6% | 0.03936239 |
| G2/M transition of mitotic cell cycle | 2 out of 47 genes, 4.3% | 4 out of 533 genes, 0.8% | 0.04073929 |
| cellular response to oxidative stress | 2 out of 47 genes, 4.3% | 4 out of 533 genes, 0.8% | 0.04073929 |
| cellular response to reactive oxygen species | 2 out of 47 genes, 4.3% | 4 out of 533 genes, 0.8% | 0.04073929 |
| ribosomal small subunit biogenesis | 2 out of 47 genes, 4.3% | 4 out of 533 genes, 0.8% | 0.04073929 |
| response to wounding | 5 out of 47 genes, 10.6% | 23 out of 533 genes, 4.3% | 0.04299832 |
| defense response | 4 out of 47 genes, 8.5% | 16 out of 533 genes, 3.0% | 0.04388069 |
| axonogenesis | 4 out of 47 genes, 8.5% | 16 out of 533 genes, 3.0% | 0.04388069 |
| neuron projection development | 4 out of 47 genes, 8.5% | 16 out of 533 genes, 3.0% | 0.04388069 |
| cell morphogenesis involved in neuron differentiation | 4 out of 47 genes, 8.5% | 16 out of 533 genes, 3.0% | 0.04388069 |
| neuron projection morphogenesis | 4 out of 47 genes, 8.5% | 16 out of 533 genes, 3.0% | 0.04388069 |
| cell motility | 4 out of 47 genes, 8.5% | 16 out of 533 genes, 3.0% | 0.04388069 |
| localization of cell | 4 out of 47 genes, 8.5% | 16 out of 533 genes, 3.0% | 0.04388069 |
| anatomical structure morphogenesis | 7 out of 47 genes, 14.9% | 39 out of 533 genes, 7.3% | 0.04531841 |
| cell differentiation | 9 out of 47 genes, 19.1% | 56 out of 533 genes, 10.5% | 0.04541172 |
| multicellular organismal process | 13 out of 47 genes, 27.7% | 93 out of 533 genes, 17.4% | 0.04693887 |
| DNA packaging | 3 out of 47 genes, 6.4% | 10 out of 533 genes, 1.9% | 0.04965448 |
| tissue development | 4 out of 47 genes, 8.5% | 17 out of 533 genes, 3.2% | 0.0537273 |
| response to stress | 11 out of 47 genes, 23.4% | 76 out of 533 genes, 14.3% | 0.05448456 |
| spindle organization | 2 out of 47 genes, 4.3% | 5 out of 533 genes, 0.9% | 0.06411012 |
| sexual reproduction | 3 out of 47 genes, 6.4% | 11 out of 533 genes, 2.1% | 0.06411995 |
| DNA conformation change | 3 out of 47 genes, 6.4% | 11 out of 533 genes, 2.1% | 0.06411995 |
| cell morphogenesis involved in differentiation | 4 out of 47 genes, 8.5% | 18 out of 533 genes, 3.4% | 0.06468751 |
| single-multicellular organism process | 12 out of 47 genes, 25.5% | 88 out of 533 genes, 16.5% | 0.06691953 |
| cellular developmental process | 9 out of 47 genes, 19.1% | 61 out of 533 genes, 11.4% | 0.07329805 |
| neuron development | 4 out of 47 genes, 8.5% | 19 out of 533 genes, 3.6% | 0.07674162 |
| cellular response to oxygen-containing compound | 4 out of 47 genes, 8.5% | 19 out of 533 genes, 3.6% | 0.07674162 |
| neurogenesis | 5 out of 47 genes, 10.6% | 27 out of 533 genes, 5.1% | 0.07878095 |
| generation of neurons | 5 out of 47 genes, 10.6% | 27 out of 533 genes, 5.1% | 0.07878095 |
| response to oxygen-containing compound | 5 out of 47 genes, 10.6% | 27 out of 533 genes, 5.1% | 0.07878095 |
| blood coagulation | 3 out of 47 genes, 6.4% | 12 out of 533 genes, 2.3% | 0.0803097 |
| hemostasis | 3 out of 47 genes, 6.4% | 12 out of 533 genes, 2.3% | 0.0803097 |
| response to inorganic substance | 3 out of 47 genes, 6.4% | 12 out of 533 genes, 2.3% | 0.0803097 |
| coagulation | 3 out of 47 genes, 6.4% | 12 out of 533 genes, 2.3% | 0.0803097 |
| response to chemical stimulus | 10 out of 47 genes, 21.3% | 72 out of 533 genes, 13.5% | 0.08446942 |
| cell part morphogenesis | 4 out of 47 genes, 8.5% | 20 out of 533 genes, 3.8% | 0.08985838 |
| cell projection morphogenesis | 4 out of 47 genes, 8.5% | 20 out of 533 genes, 3.8% | 0.08985838 |
| response to reactive oxygen species | 2 out of 47 genes, 4.3% | 6 out of 533 genes, 1.1% | 0.09083387 |
| ATP catabolic process | 2 out of 47 genes, 4.3% | 6 out of 533 genes, 1.1% | 0.09083387 |
| negative regulation of actin filament depolymerization | 2 out of 47 genes, 4.3% | 6 out of 533 genes, 1.1% | 0.09083387 |
| negative regulation of actin filament polymerization | 2 out of 47 genes, 4.3% | 6 out of 533 genes, 1.1% | 0.09083387 |
| erythrocyte homeostasis | 2 out of 47 genes, 4.3% | 6 out of 533 genes, 1.1% | 0.09083387 |
| cell cycle phase transition | 2 out of 47 genes, 4.3% | 6 out of 533 genes, 1.1% | 0.09083387 |
| mitotic cell cycle phase transition | 2 out of 47 genes, 4.3% | 6 out of 533 genes, 1.1% | 0.09083387 |
| actin filament capping | 2 out of 47 genes, 4.3% | 6 out of 533 genes, 1.1% | 0.09083387 |
| response to stimulus | 20 out of 47 genes, 42.6% | 175 out of 533 genes, 32.8% | 0.09438457 |
| ion transport | 3 out of 47 genes, 6.4% | 13 out of 533 genes, 2.4% | 0.09809667 |
| organ morphogenesis | 3 out of 47 genes, 6.4% | 13 out of 533 genes, 2.4% | 0.09809667 |
| single organism reproductive process | 3 out of 47 genes, 6.4% | 13 out of 533 genes, 2.4% | 0.09809667 |
| regulation of anatomical structure size | 3 out of 47 genes, 6.4% | 13 out of 533 genes, 2.4% | 0.09809667 |
| cellular component assembly | 10 out of 47 genes, 21.3% | 74 out of 533 genes, 13.9% | 0.09836262 |
| anatomical structure development | 10 out of 47 genes, 21.3% | 74 out of 533 genes, 13.9% | 0.09836262 |
| single-organism developmental process | 9 out of 47 genes, 19.1% | 65 out of 533 genes, 12.2% | 0.10215 |
| cellular macromolecular complex assembly | 5 out of 47 genes, 10.6% | 30 out of 533 genes, 5.6% | 0.1137289 |
| protein targeting | 6 out of 47 genes, 12.8% | 39 out of 533 genes, 7.3% | 0.1168657 |
| regulation of body fluid levels | 3 out of 47 genes, 6.4% | 14 out of 533 genes, 2.6% | 0.1173389 |
| cell morphogenesis | 4 out of 47 genes, 8.5% | 22 out of 533 genes, 4.1% | 0.1191055 |
| inflammatory response | 2 out of 47 genes, 4.3% | 7 out of 533 genes, 1.3% | 0.1201641 |
| response to metal ion | 2 out of 47 genes, 4.3% | 7 out of 533 genes, 1.3% | 0.1201641 |
| regulation of actin filament depolymerization | 2 out of 47 genes, 4.3% | 7 out of 533 genes, 1.3% | 0.1201641 |
| negative regulation of protein polymerization | 2 out of 47 genes, 4.3% | 7 out of 533 genes, 1.3% | 0.1201641 |
| cell junction assembly | 2 out of 47 genes, 4.3% | 7 out of 533 genes, 1.3% | 0.1201641 |
| response to drug | 2 out of 47 genes, 4.3% | 7 out of 533 genes, 1.3% | 0.1201641 |
| negative regulation of protein complex disassembly | 2 out of 47 genes, 4.3% | 7 out of 533 genes, 1.3% | 0.1201641 |
| protein polymerization | 2 out of 47 genes, 4.3% | 7 out of 533 genes, 1.3% | 0.1201641 |
| organelle assembly | 2 out of 47 genes, 4.3% | 7 out of 533 genes, 1.3% | 0.1201641 |
| negative regulation of protein depolymerization | 2 out of 47 genes, 4.3% | 7 out of 533 genes, 1.3% | 0.1201641 |
| regulation of multicellular organismal process | 7 out of 47 genes, 14.9% | 49 out of 533 genes, 9.2% | 0.1268219 |
| organ development | 5 out of 47 genes, 10.6% | 31 out of 533 genes, 5.8% | 0.126836 |
| viral infectious cycle | 4 out of 47 genes, 8.5% | 23 out of 533 genes, 4.3% | 0.135128 |
| M phase | 3 out of 47 genes, 6.4% | 15 out of 533 genes, 2.8% | 0.137885 |
| cell migration | 3 out of 47 genes, 6.4% | 15 out of 533 genes, 2.8% | 0.137885 |
| regulation of cell migration | 3 out of 47 genes, 6.4% | 15 out of 533 genes, 2.8% | 0.137885 |
| regulation of locomotion | 3 out of 47 genes, 6.4% | 15 out of 533 genes, 2.8% | 0.137885 |
| regulation of cell motility | 3 out of 47 genes, 6.4% | 15 out of 533 genes, 2.8% | 0.137885 |
| cellular component biogenesis | 11 out of 47 genes, 23.4% | 89 out of 533 genes, 16.7% | 0.1394972 |
| cellular process involved in reproduction | 5 out of 47 genes, 10.6% | 32 out of 533 genes, 6.0% | 0.1406258 |
| cellular nitrogen compound catabolic process | 9 out of 47 genes, 19.1% | 70 out of 533 genes, 13.1% | 0.1465074 |
| heterocycle catabolic process | 9 out of 47 genes, 19.1% | 70 out of 533 genes, 13.1% | 0.1465074 |
| organic cyclic compound catabolic process | 9 out of 47 genes, 19.1% | 70 out of 533 genes, 13.1% | 0.1465074 |
| intracellular protein transport | 7 out of 47 genes, 14.9% | 51 out of 533 genes, 9.6% | 0.1489418 |
| blood vessel development | 2 out of 47 genes, 4.3% | 8 out of 533 genes, 1.5% | 0.1514552 |
| vasculature development | 2 out of 47 genes, 4.3% | 8 out of 533 genes, 1.5% | 0.1514552 |
| response to oxidative stress | 2 out of 47 genes, 4.3% | 8 out of 533 genes, 1.5% | 0.1514552 |
| negative regulation of protein complex assembly | 2 out of 47 genes, 4.3% | 8 out of 533 genes, 1.5% | 0.1514552 |
| homeostasis of number of cells | 2 out of 47 genes, 4.3% | 8 out of 533 genes, 1.5% | 0.1514552 |
| negative regulation of cytoskeleton organization | 2 out of 47 genes, 4.3% | 8 out of 533 genes, 1.5% | 0.1514552 |
| anatomical structure homeostasis | 2 out of 47 genes, 4.3% | 8 out of 533 genes, 1.5% | 0.1514552 |
| regulation of protein depolymerization | 2 out of 47 genes, 4.3% | 8 out of 533 genes, 1.5% | 0.1514552 |
| multicellular organismal development | 9 out of 47 genes, 19.1% | 71 out of 533 genes, 13.3% | 0.1564493 |
| regulation of cellular component movement | 3 out of 47 genes, 6.4% | 16 out of 533 genes, 3.0% | 0.1595784 |
| protein transport | 9 out of 47 genes, 19.1% | 72 out of 533 genes, 13.5% | 0.1667322 |
| translational elongation | 4 out of 47 genes, 8.5% | 25 out of 533 genes, 4.7% | 0.1696541 |
| establishment of protein localization | 9 out of 47 genes, 19.1% | 73 out of 533 genes, 13.7% | 0.1773468 |
| cellular catabolic process | 12 out of 47 genes, 25.5% | 104 out of 533 genes, 19.5% | 0.1827542 |
| nucleosome assembly | 2 out of 47 genes, 4.3% | 9 out of 533 genes, 1.7% | 0.1841512 |
| negative regulation of organelle organization | 2 out of 47 genes, 4.3% | 9 out of 533 genes, 1.7% | 0.1841512 |
| regulation of actin filament polymerization | 2 out of 47 genes, 4.3% | 9 out of 533 genes, 1.7% | 0.1841512 |
| chromatin assembly | 2 out of 47 genes, 4.3% | 9 out of 533 genes, 1.7% | 0.1841512 |
| cell junction organization | 2 out of 47 genes, 4.3% | 9 out of 533 genes, 1.7% | 0.1841512 |
| regulation of protein complex disassembly | 2 out of 47 genes, 4.3% | 9 out of 533 genes, 1.7% | 0.1841512 |
| cellular protein complex assembly | 2 out of 47 genes, 4.3% | 9 out of 533 genes, 1.7% | 0.1841512 |
| ATP metabolic process | 2 out of 47 genes, 4.3% | 9 out of 533 genes, 1.7% | 0.1841512 |
| organic hydroxy compound metabolic process | 2 out of 47 genes, 4.3% | 9 out of 533 genes, 1.7% | 0.1841512 |
| single-organism transport | 11 out of 47 genes, 23.4% | 94 out of 533 genes, 17.6% | 0.1854472 |
| biological regulation | 28 out of 47 genes, 59.6% | 279 out of 533 genes, 52.3% | 0.1879418 |
| protein targeting to membrane | 4 out of 47 genes, 8.5% | 26 out of 533 genes, 4.9% | 0.1880171 |
| reproduction | 7 out of 47 genes, 14.9% | 55 out of 533 genes, 10.3% | 0.1983624 |
| nervous system development | 5 out of 47 genes, 10.6% | 36 out of 533 genes, 6.8% | 0.2018848 |
| protein localization to organelle | 5 out of 47 genes, 10.6% | 36 out of 533 genes, 6.8% | 0.2018848 |
| nuclear-transcribed mRNA catabolic process | 4 out of 47 genes, 8.5% | 27 out of 533 genes, 5.1% | 0.2070147 |
| chromosome organization | 4 out of 47 genes, 8.5% | 27 out of 533 genes, 5.1% | 0.2070147 |
| establishment of protein localization to organelle | 4 out of 47 genes, 8.5% | 27 out of 533 genes, 5.1% | 0.2070147 |
| regulation of response to stress | 4 out of 47 genes, 8.5% | 27 out of 533 genes, 5.1% | 0.2070147 |
| nucleobase-containing compound catabolic process | 8 out of 47 genes, 17.0% | 66 out of 533 genes, 12.4% | 0.2121937 |
| nuclear division | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| chromatin assembly or disassembly | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| mitosis | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| regulation of actin polymerization or depolymerization | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| positive regulation of cell migration | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| regulation of actin filament length | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| regulation of protein polymerization | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| nucleosome organization | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| positive regulation of locomotion | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| organelle fission | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| protein-DNA complex assembly | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| positive regulation of cell motility | 2 out of 47 genes, 4.3% | 10 out of 533 genes, 1.9% | 0.2177754 |
| aromatic compound catabolic process | 8 out of 47 genes, 17.0% | 67 out of 533 genes, 12.6% | 0.2248571 |
| RNA catabolic process | 4 out of 47 genes, 8.5% | 28 out of 533 genes, 5.3% | 0.2265707 |
| mRNA catabolic process | 4 out of 47 genes, 8.5% | 28 out of 533 genes, 5.3% | 0.2265707 |
| cellular component disassembly | 4 out of 47 genes, 8.5% | 28 out of 533 genes, 5.3% | 0.2265707 |
| immune system process | 5 out of 47 genes, 10.6% | 38 out of 533 genes, 7.1% | 0.2355869 |
| cellular response to chemical stimulus | 6 out of 47 genes, 12.8% | 48 out of 533 genes, 9.0% | 0.2390256 |
| M phase of mitotic cell cycle | 2 out of 47 genes, 4.3% | 11 out of 533 genes, 2.1% | 0.2519211 |
| microtubule cytoskeleton organization | 2 out of 47 genes, 4.3% | 11 out of 533 genes, 2.1% | 0.2519211 |
| regulation of cytokine production | 2 out of 47 genes, 4.3% | 11 out of 533 genes, 2.1% | 0.2519211 |
| rRNA processing | 2 out of 47 genes, 4.3% | 11 out of 533 genes, 2.1% | 0.2519211 |
| rRNA metabolic process | 2 out of 47 genes, 4.3% | 11 out of 533 genes, 2.1% | 0.2519211 |
| regulation of actin cytoskeleton organization | 2 out of 47 genes, 4.3% | 11 out of 533 genes, 2.1% | 0.2519211 |
| regulation of actin filament-based process | 2 out of 47 genes, 4.3% | 11 out of 533 genes, 2.1% | 0.2519211 |
| positive regulation of multicellular organismal process | 2 out of 47 genes, 4.3% | 11 out of 533 genes, 2.1% | 0.2519211 |
| positive regulation of cellular component movement | 2 out of 47 genes, 4.3% | 11 out of 533 genes, 2.1% | 0.2519211 |
| protein-DNA complex subunit organization | 2 out of 47 genes, 4.3% | 11 out of 533 genes, 2.1% | 0.2519211 |
| cellular process | 42 out of 47 genes, 89.4% | 453 out of 533 genes, 85.0% | 0.261066 |
| cell adhesion | 4 out of 47 genes, 8.5% | 30 out of 533 genes, 5.6% | 0.2670516 |
| biological adhesion | 4 out of 47 genes, 8.5% | 30 out of 533 genes, 5.6% | 0.2670516 |
| cellular protein localization | 7 out of 47 genes, 14.9% | 60 out of 533 genes, 11.3% | 0.2682487 |
| cellular macromolecule localization | 7 out of 47 genes, 14.9% | 60 out of 533 genes, 11.3% | 0.2682487 |
| reproductive process | 6 out of 47 genes, 12.8% | 50 out of 533 genes, 9.4% | 0.2706405 |
| macromolecular complex assembly | 6 out of 47 genes, 12.8% | 50 out of 533 genes, 9.4% | 0.2706405 |
| organonitrogen compound catabolic process | 5 out of 47 genes, 10.6% | 40 out of 533 genes, 7.5% | 0.2708462 |
| translational termination | 3 out of 47 genes, 6.4% | 21 out of 533 genes, 3.9% | 0.279811 |
| lipid metabolic process | 3 out of 47 genes, 6.4% | 21 out of 533 genes, 3.9% | 0.279811 |
| microtubule-based process | 3 out of 47 genes, 6.4% | 21 out of 533 genes, 3.9% | 0.279811 |
| viral genome expression | 3 out of 47 genes, 6.4% | 21 out of 533 genes, 3.9% | 0.279811 |
| viral transcription | 3 out of 47 genes, 6.4% | 21 out of 533 genes, 3.9% | 0.279811 |
| cellular homeostasis | 2 out of 47 genes, 4.3% | 12 out of 533 genes, 2.3% | 0.2862433 |
| regulation of cellular component size | 2 out of 47 genes, 4.3% | 12 out of 533 genes, 2.3% | 0.2862433 |
| catabolic process | 12 out of 47 genes, 25.5% | 115 out of 533 genes, 21.6% | 0.2994683 |
| regulation of localization | 6 out of 47 genes, 12.8% | 52 out of 533 genes, 9.8% | 0.3033269 |
| developmental process | 10 out of 47 genes, 21.3% | 94 out of 533 genes, 17.6% | 0.3042571 |
| localization | 15 out of 47 genes, 31.9% | 148 out of 533 genes, 27.8% | 0.3051589 |
| chromatin organization | 3 out of 47 genes, 6.4% | 22 out of 533 genes, 4.1% | 0.3051856 |
| protein complex disassembly | 3 out of 47 genes, 6.4% | 22 out of 533 genes, 4.1% | 0.3051856 |
| cellular protein complex disassembly | 3 out of 47 genes, 6.4% | 22 out of 533 genes, 4.1% | 0.3051856 |
| viral reproduction | 5 out of 47 genes, 10.6% | 42 out of 533 genes, 7.9% | 0.3072771 |
| multi-organism cellular process | 5 out of 47 genes, 10.6% | 42 out of 533 genes, 7.9% | 0.3072771 |
| protein localization | 9 out of 47 genes, 19.1% | 84 out of 533 genes, 15.8% | 0.3124562 |
| organic substance transport | 9 out of 47 genes, 19.1% | 84 out of 533 genes, 15.8% | 0.3124562 |
| microtubule-based movement | 2 out of 47 genes, 4.3% | 13 out of 533 genes, 2.4% | 0.3204518 |
| regulation of I-kappaB kinase/NF-kappaB cascade | 2 out of 47 genes, 4.3% | 13 out of 533 genes, 2.4% | 0.3204518 |
| cellular response to organic nitrogen | 2 out of 47 genes, 4.3% | 13 out of 533 genes, 2.4% | 0.3204518 |
| nitrogen compound transport | 2 out of 47 genes, 4.3% | 13 out of 533 genes, 2.4% | 0.3204518 |
| purine nucleoside catabolic process | 4 out of 47 genes, 8.5% | 33 out of 533 genes, 6.2% | 0.3300648 |
| nucleoside triphosphate catabolic process | 4 out of 47 genes, 8.5% | 33 out of 533 genes, 6.2% | 0.3300648 |
| purine nucleoside triphosphate catabolic process | 4 out of 47 genes, 8.5% | 33 out of 533 genes, 6.2% | 0.3300648 |
| nucleoside catabolic process | 4 out of 47 genes, 8.5% | 33 out of 533 genes, 6.2% | 0.3300648 |
| ribonucleoside triphosphate catabolic process | 4 out of 47 genes, 8.5% | 33 out of 533 genes, 6.2% | 0.3300648 |
| purine ribonucleoside triphosphate catabolic process | 4 out of 47 genes, 8.5% | 33 out of 533 genes, 6.2% | 0.3300648 |
| ribonucleoside catabolic process | 4 out of 47 genes, 8.5% | 33 out of 533 genes, 6.2% | 0.3300648 |
| purine ribonucleoside catabolic process | 4 out of 47 genes, 8.5% | 33 out of 533 genes, 6.2% | 0.3300648 |
| glycosyl compound catabolic process | 4 out of 47 genes, 8.5% | 33 out of 533 genes, 6.2% | 0.3300648 |
| cell cycle phase | 3 out of 47 genes, 6.4% | 23 out of 533 genes, 4.3% | 0.3306942 |
| macromolecular complex disassembly | 3 out of 47 genes, 6.4% | 23 out of 533 genes, 4.3% | 0.3306942 |
| multi-organism process | 6 out of 47 genes, 12.8% | 54 out of 533 genes, 10.1% | 0.3368085 |
| purine nucleotide catabolic process | 4 out of 47 genes, 8.5% | 34 out of 533 genes, 6.4% | 0.3513915 |
| DNA metabolic process | 4 out of 47 genes, 8.5% | 34 out of 533 genes, 6.4% | 0.3513915 |
| purine ribonucleotide catabolic process | 4 out of 47 genes, 8.5% | 34 out of 533 genes, 6.4% | 0.3513915 |
| nucleotide catabolic process | 4 out of 47 genes, 8.5% | 34 out of 533 genes, 6.4% | 0.3513915 |
| ribonucleotide catabolic process | 4 out of 47 genes, 8.5% | 34 out of 533 genes, 6.4% | 0.3513915 |
| organophosphate catabolic process | 4 out of 47 genes, 8.5% | 34 out of 533 genes, 6.4% | 0.3513915 |
| purine-containing compound catabolic process | 4 out of 47 genes, 8.5% | 34 out of 533 genes, 6.4% | 0.3513915 |
| nucleoside phosphate catabolic process | 4 out of 47 genes, 8.5% | 34 out of 533 genes, 6.4% | 0.3513915 |
| response to organic cyclic compound | 2 out of 47 genes, 4.3% | 14 out of 533 genes, 2.6% | 0.354304 |
| cellular lipid metabolic process | 2 out of 47 genes, 4.3% | 14 out of 533 genes, 2.6% | 0.354304 |
| small molecule biosynthetic process | 2 out of 47 genes, 4.3% | 14 out of 533 genes, 2.6% | 0.354304 |
| positive regulation of transport | 2 out of 47 genes, 4.3% | 14 out of 533 genes, 2.6% | 0.354304 |
| negative regulation of developmental process | 2 out of 47 genes, 4.3% | 14 out of 533 genes, 2.6% | 0.354304 |
| regulation of protein transport | 2 out of 47 genes, 4.3% | 14 out of 533 genes, 2.6% | 0.354304 |
| cell division | 2 out of 47 genes, 4.3% | 14 out of 533 genes, 2.6% | 0.354304 |
| cellular response to nitrogen compound | 2 out of 47 genes, 4.3% | 14 out of 533 genes, 2.6% | 0.354304 |
| mitotic cell cycle | 3 out of 47 genes, 6.4% | 24 out of 533 genes, 4.5% | 0.3562219 |
| cotranslational protein targeting to membrane | 3 out of 47 genes, 6.4% | 24 out of 533 genes, 4.5% | 0.3562219 |
| SRP-dependent cotranslational protein targeting to membrane | 3 out of 47 genes, 6.4% | 24 out of 533 genes, 4.5% | 0.3562219 |
| negative regulation of signal transduction | 3 out of 47 genes, 6.4% | 24 out of 533 genes, 4.5% | 0.3562219 |
| protein targeting to ER | 3 out of 47 genes, 6.4% | 24 out of 533 genes, 4.5% | 0.3562219 |
| protein localization to endoplasmic reticulum | 3 out of 47 genes, 6.4% | 24 out of 533 genes, 4.5% | 0.3562219 |
| establishment of protein localization to endoplasmic reticulum | 3 out of 47 genes, 6.4% | 24 out of 533 genes, 4.5% | 0.3562219 |
| transport | 13 out of 47 genes, 27.7% | 132 out of 533 genes, 24.8% | 0.3720725 |
| carbohydrate derivative catabolic process | 4 out of 47 genes, 8.5% | 35 out of 533 genes, 6.6% | 0.3727664 |
| intracellular transport | 8 out of 47 genes, 17.0% | 78 out of 533 genes, 14.6% | 0.3791923 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3 out of 47 genes, 6.4% | 25 out of 533 genes, 4.7% | 0.381663 |
| organic substance catabolic process | 11 out of 47 genes, 23.4% | 111 out of 533 genes, 20.8% | 0.3837662 |
| establishment of localization | 13 out of 47 genes, 27.7% | 133 out of 533 genes, 25.0% | 0.3840931 |
| cell-cell signaling | 2 out of 47 genes, 4.3% | 15 out of 533 genes, 2.8% | 0.3875992 |
| ncRNA processing | 2 out of 47 genes, 4.3% | 15 out of 533 genes, 2.8% | 0.3875992 |
| regulation of protein complex assembly | 2 out of 47 genes, 4.3% | 15 out of 533 genes, 2.8% | 0.3875992 |
| single-organism biosynthetic process | 2 out of 47 genes, 4.3% | 15 out of 533 genes, 2.8% | 0.3875992 |
| negative regulation of cellular component organization | 2 out of 47 genes, 4.3% | 15 out of 533 genes, 2.8% | 0.3875992 |
| regulation of establishment of protein localization | 2 out of 47 genes, 4.3% | 15 out of 533 genes, 2.8% | 0.3875992 |
| regulation of cellular response to stress | 2 out of 47 genes, 4.3% | 15 out of 533 genes, 2.8% | 0.3875992 |
| regulation of signal transduction | 6 out of 47 genes, 12.8% | 58 out of 533 genes, 10.9% | 0.4050605 |
| regulation of immune system process | 3 out of 47 genes, 6.4% | 26 out of 533 genes, 4.9% | 0.4069211 |
| negative regulation of cell communication | 3 out of 47 genes, 6.4% | 26 out of 533 genes, 4.9% | 0.4069211 |
| negative regulation of signaling | 3 out of 47 genes, 6.4% | 26 out of 533 genes, 4.9% | 0.4069211 |
| regulation of hydrolase activity | 3 out of 47 genes, 6.4% | 26 out of 533 genes, 4.9% | 0.4069211 |
| viral reproductive process | 4 out of 47 genes, 8.5% | 37 out of 533 genes, 6.9% | 0.4154126 |
| regulation of developmental process | 4 out of 47 genes, 8.5% | 37 out of 533 genes, 6.9% | 0.4154126 |
| chromatin modification | 2 out of 47 genes, 4.3% | 16 out of 533 genes, 3.0% | 0.4201736 |
| regulation of cytoskeleton organization | 2 out of 47 genes, 4.3% | 16 out of 533 genes, 3.0% | 0.4201736 |
| response to growth factor stimulus | 2 out of 47 genes, 4.3% | 16 out of 533 genes, 3.0% | 0.4201736 |
| cellular response to growth factor stimulus | 2 out of 47 genes, 4.3% | 16 out of 533 genes, 3.0% | 0.4201736 |
| multi-organism reproductive process | 4 out of 47 genes, 8.5% | 38 out of 533 genes, 7.1% | 0.4365685 |
| establishment of localization in cell | 8 out of 47 genes, 17.0% | 82 out of 533 genes, 15.4% | 0.4387874 |
| regulation of response to stimulus | 7 out of 47 genes, 14.9% | 71 out of 533 genes, 13.3% | 0.439282 |
| apoptotic process | 2 out of 47 genes, 4.3% | 17 out of 533 genes, 3.2% | 0.4518953 |
| programmed cell death | 2 out of 47 genes, 4.3% | 17 out of 533 genes, 3.2% | 0.4518953 |
| negative regulation of apoptotic process | 2 out of 47 genes, 4.3% | 17 out of 533 genes, 3.2% | 0.4518953 |
| regulation of cellular component biogenesis | 2 out of 47 genes, 4.3% | 17 out of 533 genes, 3.2% | 0.4518953 |
| chemical homeostasis | 2 out of 47 genes, 4.3% | 17 out of 533 genes, 3.2% | 0.4518953 |
| macromolecule localization | 9 out of 47 genes, 19.1% | 94 out of 533 genes, 17.6% | 0.4521258 |
| translational initiation | 3 out of 47 genes, 6.4% | 28 out of 533 genes, 5.3% | 0.4565501 |
| response to endogenous stimulus | 3 out of 47 genes, 6.4% | 28 out of 533 genes, 5.3% | 0.4565501 |
| negative regulation of response to stimulus | 3 out of 47 genes, 6.4% | 28 out of 533 genes, 5.3% | 0.4565501 |
| cytoplasmic transport | 5 out of 47 genes, 10.6% | 50 out of 533 genes, 9.4% | 0.4572451 |
| purine nucleoside triphosphate metabolic process | 4 out of 47 genes, 8.5% | 39 out of 533 genes, 7.3% | 0.4575426 |
| purine ribonucleoside triphosphate metabolic process | 4 out of 47 genes, 8.5% | 39 out of 533 genes, 7.3% | 0.4575426 |
| cellular response to organic substance | 4 out of 47 genes, 8.5% | 39 out of 533 genes, 7.3% | 0.4575426 |
| translation | 5 out of 47 genes, 10.6% | 51 out of 533 genes, 9.6% | 0.4757645 |
| ribonucleoside triphosphate metabolic process | 4 out of 47 genes, 8.5% | 40 out of 533 genes, 7.5% | 0.4782866 |
| purine nucleoside metabolic process | 4 out of 47 genes, 8.5% | 40 out of 533 genes, 7.5% | 0.4782866 |
| purine ribonucleoside metabolic process | 4 out of 47 genes, 8.5% | 40 out of 533 genes, 7.5% | 0.4782866 |
| protein complex assembly | 3 out of 47 genes, 6.4% | 29 out of 533 genes, 5.4% | 0.4807741 |
| protein folding | 2 out of 47 genes, 4.3% | 18 out of 533 genes, 3.4% | 0.4826603 |
| cell death | 2 out of 47 genes, 4.3% | 18 out of 533 genes, 3.4% | 0.4826603 |
| response to organic nitrogen | 2 out of 47 genes, 4.3% | 18 out of 533 genes, 3.4% | 0.4826603 |
| death | 2 out of 47 genes, 4.3% | 18 out of 533 genes, 3.4% | 0.4826603 |
| ribosome biogenesis | 2 out of 47 genes, 4.3% | 18 out of 533 genes, 3.4% | 0.4826603 |
| negative regulation of programmed cell death | 2 out of 47 genes, 4.3% | 18 out of 533 genes, 3.4% | 0.4826603 |
| negative regulation of cell death | 2 out of 47 genes, 4.3% | 18 out of 533 genes, 3.4% | 0.4826603 |
| macromolecule catabolic process | 6 out of 47 genes, 12.8% | 63 out of 533 genes, 11.8% | 0.4901339 |
| organic cyclic compound metabolic process | 16 out of 47 genes, 34.0% | 176 out of 533 genes, 33.0% | 0.4964386 |
| nucleoside triphosphate metabolic process | 4 out of 47 genes, 8.5% | 41 out of 533 genes, 7.7% | 0.4987566 |
| protein complex biogenesis | 3 out of 47 genes, 6.4% | 30 out of 533 genes, 5.6% | 0.5045211 |
| response to organic substance | 5 out of 47 genes, 10.6% | 53 out of 533 genes, 9.9% | 0.5122467 |
| positive regulation of protein phosphorylation | 2 out of 47 genes, 4.3% | 19 out of 533 genes, 3.6% | 0.5123887 |
| ribonucleoside metabolic process | 4 out of 47 genes, 8.5% | 42 out of 533 genes, 7.9% | 0.5189123 |
| regulation of phosphate metabolic process | 4 out of 47 genes, 8.5% | 42 out of 533 genes, 7.9% | 0.5189123 |
| regulation of phosphorus metabolic process | 4 out of 47 genes, 8.5% | 42 out of 533 genes, 7.9% | 0.5189123 |
| cellular response to stimulus | 12 out of 47 genes, 25.5% | 133 out of 533 genes, 25.0% | 0.52226 |
| purine nucleotide metabolic process | 4 out of 47 genes, 8.5% | 43 out of 533 genes, 8.1% | 0.5387175 |
| nucleoside metabolic process | 4 out of 47 genes, 8.5% | 43 out of 533 genes, 8.1% | 0.5387175 |
| purine ribonucleotide metabolic process | 4 out of 47 genes, 8.5% | 43 out of 533 genes, 8.1% | 0.5387175 |
| purine-containing compound metabolic process | 4 out of 47 genes, 8.5% | 43 out of 533 genes, 8.1% | 0.5387175 |
| glycosyl compound metabolic process | 4 out of 47 genes, 8.5% | 43 out of 533 genes, 8.1% | 0.5387175 |
| regulation of cell communication | 6 out of 47 genes, 12.8% | 66 out of 533 genes, 12.4% | 0.5396768 |
| cellular membrane organization | 2 out of 47 genes, 4.3% | 20 out of 533 genes, 3.8% | 0.5410213 |
| regulation of protein localization | 2 out of 47 genes, 4.3% | 20 out of 533 genes, 3.8% | 0.5410213 |
| positive regulation of phosphorylation | 2 out of 47 genes, 4.3% | 20 out of 533 genes, 3.8% | 0.5410213 |
| membrane organization | 2 out of 47 genes, 4.3% | 20 out of 533 genes, 3.8% | 0.5410213 |
| organonitrogen compound biosynthetic process | 2 out of 47 genes, 4.3% | 20 out of 533 genes, 3.8% | 0.5410213 |
| response to nitrogen compound | 2 out of 47 genes, 4.3% | 20 out of 533 genes, 3.8% | 0.5410213 |
| cellular aromatic compound metabolic process | 15 out of 47 genes, 31.9% | 169 out of 533 genes, 31.7% | 0.5459616 |
| nucleobase-containing small molecule metabolic process | 5 out of 47 genes, 10.6% | 55 out of 533 genes, 10.3% | 0.5477873 |
| regulation of intracellular protein kinase cascade | 3 out of 47 genes, 6.4% | 32 out of 533 genes, 6.0% | 0.5503819 |
| regulation of signaling | 6 out of 47 genes, 12.8% | 67 out of 533 genes, 12.6% | 0.5557949 |
| ribonucleotide metabolic process | 4 out of 47 genes, 8.5% | 44 out of 533 genes, 8.3% | 0.5581398 |
| ribose phosphate metabolic process | 4 out of 47 genes, 8.5% | 44 out of 533 genes, 8.3% | 0.5581398 |
| ncRNA metabolic process | 2 out of 47 genes, 4.3% | 21 out of 533 genes, 3.9% | 0.5685172 |
| cellular response to endogenous stimulus | 2 out of 47 genes, 4.3% | 21 out of 533 genes, 3.9% | 0.5685172 |
| cellular localization | 8 out of 47 genes, 17.0% | 91 out of 533 genes, 17.1% | 0.5700292 |
| nucleic acid metabolic process | 10 out of 47 genes, 21.3% | 114 out of 533 genes, 21.4% | 0.5701705 |
| cell cycle process | 3 out of 47 genes, 6.4% | 33 out of 533 genes, 6.2% | 0.5724137 |
| organonitrogen compound metabolic process | 6 out of 47 genes, 12.8% | 69 out of 533 genes, 12.9% | 0.5873146 |
| positive regulation of phosphorus metabolic process | 2 out of 47 genes, 4.3% | 22 out of 533 genes, 4.1% | 0.5948503 |
| regulation of organelle organization | 2 out of 47 genes, 4.3% | 22 out of 533 genes, 4.1% | 0.5948503 |
| regulation of MAPK cascade | 2 out of 47 genes, 4.3% | 22 out of 533 genes, 4.1% | 0.5948503 |
| positive regulation of phosphate metabolic process | 2 out of 47 genes, 4.3% | 22 out of 533 genes, 4.1% | 0.5948503 |
| aromatic compound biosynthetic process | 5 out of 47 genes, 10.6% | 58 out of 533 genes, 10.9% | 0.5988875 |
| regulation of cell death | 3 out of 47 genes, 6.4% | 35 out of 533 genes, 6.6% | 0.6145251 |
| regulation of apoptotic process | 3 out of 47 genes, 6.4% | 35 out of 533 genes, 6.6% | 0.6145251 |
| regulation of programmed cell death | 3 out of 47 genes, 6.4% | 35 out of 533 genes, 6.6% | 0.6145251 |
| cellular macromolecule catabolic process | 5 out of 47 genes, 10.6% | 59 out of 533 genes, 11.1% | 0.6152476 |
| regulation of cellular localization | 2 out of 47 genes, 4.3% | 23 out of 533 genes, 4.3% | 0.620008 |
| small molecule metabolic process | 8 out of 47 genes, 17.0% | 95 out of 533 genes, 17.8% | 0.6245677 |
| nucleobase-containing compound metabolic process | 14 out of 47 genes, 29.8% | 165 out of 533 genes, 31.0% | 0.629617 |
| regulation of transport | 3 out of 47 genes, 6.4% | 36 out of 533 genes, 6.8% | 0.6345613 |
| positive regulation of protein metabolic process | 3 out of 47 genes, 6.4% | 36 out of 533 genes, 6.8% | 0.6345613 |
| small GTPase mediated signal transduction | 2 out of 47 genes, 4.3% | 24 out of 533 genes, 4.5% | 0.6439886 |
| regulation of cell differentiation | 2 out of 47 genes, 4.3% | 24 out of 533 genes, 4.5% | 0.6439886 |
| RNA biosynthetic process | 3 out of 47 genes, 6.4% | 37 out of 533 genes, 6.9% | 0.653898 |
| organic cyclic compound biosynthetic process | 5 out of 47 genes, 10.6% | 62 out of 533 genes, 11.6% | 0.6620824 |
| regulation of protein phosphorylation | 2 out of 47 genes, 4.3% | 25 out of 533 genes, 4.7% | 0.6667995 |
| ribonucleoprotein complex biogenesis | 2 out of 47 genes, 4.3% | 25 out of 533 genes, 4.7% | 0.6667995 |
| regulation of cell cycle | 2 out of 47 genes, 4.3% | 25 out of 533 genes, 4.7% | 0.6667995 |
| nitrogen compound metabolic process | 15 out of 47 genes, 31.9% | 181 out of 533 genes, 34.0% | 0.676976 |
| nucleoside phosphate metabolic process | 4 out of 47 genes, 8.5% | 51 out of 533 genes, 9.6% | 0.6813926 |
| nucleotide metabolic process | 4 out of 47 genes, 8.5% | 51 out of 533 genes, 9.6% | 0.6813926 |
| carbohydrate derivative metabolic process | 4 out of 47 genes, 8.5% | 51 out of 533 genes, 9.6% | 0.6813926 |
| heterocycle metabolic process | 14 out of 47 genes, 29.8% | 170 out of 533 genes, 31.9% | 0.6827003 |
| regulation of catalytic activity | 4 out of 47 genes, 8.5% | 52 out of 533 genes, 9.8% | 0.6969996 |
| single-organism metabolic process | 9 out of 47 genes, 19.1% | 113 out of 533 genes, 21.2% | 0.7002644 |
| cell cycle | 3 out of 47 genes, 6.4% | 40 out of 533 genes, 7.5% | 0.7076432 |
| cellular response to stress | 3 out of 47 genes, 6.4% | 40 out of 533 genes, 7.5% | 0.7076432 |
| GTP catabolic process | 2 out of 47 genes, 4.3% | 27 out of 533 genes, 5.1% | 0.7089798 |
| guanosine-containing compound catabolic process | 2 out of 47 genes, 4.3% | 27 out of 533 genes, 5.1% | 0.7089798 |
| cellular biosynthetic process | 9 out of 47 genes, 19.1% | 114 out of 533 genes, 21.4% | 0.7114153 |
| organophosphate metabolic process | 4 out of 47 genes, 8.5% | 53 out of 533 genes, 9.9% | 0.7120814 |
| mRNA metabolic process | 5 out of 47 genes, 10.6% | 66 out of 533 genes, 12.4% | 0.7188941 |
| regulation of molecular function | 5 out of 47 genes, 10.6% | 66 out of 533 genes, 12.4% | 0.7188941 |
| cellular nitrogen compound metabolic process | 14 out of 47 genes, 29.8% | 174 out of 533 genes, 32.6% | 0.7223062 |
| macromolecule biosynthetic process | 6 out of 47 genes, 12.8% | 79 out of 533 genes, 14.8% | 0.7268581 |
| cellular macromolecule biosynthetic process | 6 out of 47 genes, 12.8% | 79 out of 533 genes, 14.8% | 0.7268581 |
| positive regulation of protein modification process | 2 out of 47 genes, 4.3% | 28 out of 533 genes, 5.3% | 0.7283975 |
| regulation of phosphorylation | 2 out of 47 genes, 4.3% | 28 out of 533 genes, 5.3% | 0.7283975 |
| regulation of biological process | 22 out of 47 genes, 46.8% | 267 out of 533 genes, 50.1% | 0.7336688 |
| nucleobase-containing compound biosynthetic process | 4 out of 47 genes, 8.5% | 55 out of 533 genes, 10.3% | 0.7406634 |
| organic acid metabolic process | 2 out of 47 genes, 4.3% | 29 out of 533 genes, 5.4% | 0.7467399 |
| carboxylic acid metabolic process | 2 out of 47 genes, 4.3% | 29 out of 533 genes, 5.4% | 0.7467399 |
| oxoacid metabolic process | 2 out of 47 genes, 4.3% | 29 out of 533 genes, 5.4% | 0.7467399 |
| organic substance biosynthetic process | 9 out of 47 genes, 19.1% | 118 out of 533 genes, 22.1% | 0.7535206 |
| positive regulation of cellular process | 8 out of 47 genes, 17.0% | 106 out of 533 genes, 19.9% | 0.7548677 |
| positive regulation of molecular function | 3 out of 47 genes, 6.4% | 43 out of 533 genes, 8.1% | 0.7550108 |
| GTP metabolic process | 2 out of 47 genes, 4.3% | 30 out of 533 genes, 5.6% | 0.7640413 |
| guanosine-containing compound metabolic process | 2 out of 47 genes, 4.3% | 30 out of 533 genes, 5.6% | 0.7640413 |
| biosynthetic process | 9 out of 47 genes, 19.1% | 120 out of 533 genes, 22.5% | 0.7730323 |
| heterocycle biosynthetic process | 4 out of 47 genes, 8.5% | 59 out of 533 genes, 11.1% | 0.7915627 |
| cellular nitrogen compound biosynthetic process | 4 out of 47 genes, 8.5% | 59 out of 533 genes, 11.1% | 0.7915627 |
| protein catabolic process | 2 out of 47 genes, 4.3% | 32 out of 533 genes, 6.0% | 0.7956684 |
| positive regulation of cellular protein metabolic process | 2 out of 47 genes, 4.3% | 32 out of 533 genes, 6.0% | 0.7956684 |
| regulation of cellular component organization | 3 out of 47 genes, 6.4% | 46 out of 533 genes, 8.6% | 0.7962255 |
| negative regulation of cellular process | 7 out of 47 genes, 14.9% | 99 out of 533 genes, 18.6% | 0.8072606 |
| negative regulation of gene expression | 2 out of 47 genes, 4.3% | 33 out of 533 genes, 6.2% | 0.8100719 |
| regulation of protein metabolic process | 4 out of 47 genes, 8.5% | 61 out of 533 genes, 11.4% | 0.8139724 |
| RNA metabolic process | 6 out of 47 genes, 12.8% | 88 out of 533 genes, 16.5% | 0.8225818 |
| positive regulation of catalytic activity | 2 out of 47 genes, 4.3% | 34 out of 533 genes, 6.4% | 0.8235888 |
| RNA processing | 3 out of 47 genes, 6.4% | 49 out of 533 genes, 9.2% | 0.8316808 |
| vesicle-mediated transport | 2 out of 47 genes, 4.3% | 35 out of 533 genes, 6.6% | 0.8362593 |
| regulation of protein modification process | 2 out of 47 genes, 4.3% | 35 out of 533 genes, 6.6% | 0.8362593 |
| intracellular signal transduction | 3 out of 47 genes, 6.4% | 50 out of 533 genes, 9.4% | 0.842303 |
| positive regulation of biological process | 8 out of 47 genes, 17.0% | 116 out of 533 genes, 21.8% | 0.8441866 |
| regulation of cellular process | 19 out of 47 genes, 40.4% | 249 out of 533 genes, 46.7% | 0.8551685 |
| positive regulation of response to stimulus | 2 out of 47 genes, 4.3% | 37 out of 533 genes, 6.9% | 0.8592225 |
| gene expression | 7 out of 47 genes, 14.9% | 107 out of 533 genes, 20.1% | 0.8707852 |
| negative regulation of biological process | 7 out of 47 genes, 14.9% | 107 out of 533 genes, 20.1% | 0.8707852 |
| positive regulation of cellular metabolic process | 4 out of 47 genes, 8.5% | 69 out of 533 genes, 12.9% | 0.8852328 |
| positive regulation of macromolecule metabolic process | 4 out of 47 genes, 8.5% | 70 out of 533 genes, 13.1% | 0.8922801 |
| signal transduction | 6 out of 47 genes, 12.8% | 99 out of 533 genes, 18.6% | 0.9025017 |
| proteolysis | 2 out of 47 genes, 4.3% | 42 out of 533 genes, 7.9% | 0.9045718 |
| positive regulation of macromolecule biosynthetic process | 2 out of 47 genes, 4.3% | 43 out of 533 genes, 8.1% | 0.9118674 |
| phosphorus metabolic process | 4 out of 47 genes, 8.5% | 75 out of 533 genes, 14.1% | 0.9222686 |
| phosphate-containing compound metabolic process | 4 out of 47 genes, 8.5% | 75 out of 533 genes, 14.1% | 0.9222686 |
| positive regulation of metabolic process | 4 out of 47 genes, 8.5% | 75 out of 533 genes, 14.1% | 0.9222686 |
| signaling | 6 out of 47 genes, 12.8% | 103 out of 533 genes, 19.3% | 0.9230011 |
| single organism signaling | 6 out of 47 genes, 12.8% | 103 out of 533 genes, 19.3% | 0.9230011 |
| positive regulation of cellular biosynthetic process | 2 out of 47 genes, 4.3% | 46 out of 533 genes, 8.6% | 0.9308045 |
| positive regulation of biosynthetic process | 2 out of 47 genes, 4.3% | 47 out of 533 genes, 8.8% | 0.9362331 |
| cell communication | 6 out of 47 genes, 12.8% | 107 out of 533 genes, 20.1% | 0.9397587 |
| primary metabolic process | 22 out of 47 genes, 46.8% | 304 out of 533 genes, 57.0% | 0.9486276 |
| regulation of primary metabolic process | 9 out of 47 genes, 19.1% | 150 out of 533 genes, 28.1% | 0.9502422 |
| regulation of cellular protein metabolic process | 2 out of 47 genes, 4.3% | 51 out of 533 genes, 9.6% | 0.9542425 |
| negative regulation of macromolecule metabolic process | 2 out of 47 genes, 4.3% | 52 out of 533 genes, 9.8% | 0.9579374 |
| regulation of metabolic process | 10 out of 47 genes, 21.3% | 166 out of 533 genes, 31.1% | 0.9587586 |
| cellular metabolic process | 21 out of 47 genes, 44.7% | 297 out of 533 genes, 55.7% | 0.9595141 |
| cellular macromolecule metabolic process | 14 out of 47 genes, 29.8% | 216 out of 533 genes, 40.5% | 0.9598039 |
| negative regulation of metabolic process | 2 out of 47 genes, 4.3% | 53 out of 533 genes, 9.9% | 0.9613522 |
| macromolecule metabolic process | 15 out of 47 genes, 31.9% | 229 out of 533 genes, 43.0% | 0.9621047 |
| metabolic process | 23 out of 47 genes, 48.9% | 321 out of 533 genes, 60.2% | 0.9639581 |
| organic substance metabolic process | 22 out of 47 genes, 46.8% | 311 out of 533 genes, 58.3% | 0.9660321 |
| protein metabolic process | 9 out of 47 genes, 19.1% | 158 out of 533 genes, 29.6% | 0.9695472 |
| cell surface receptor signaling pathway | 2 out of 47 genes, 4.3% | 56 out of 533 genes, 10.5% | 0.9701047 |
| regulation of cellular metabolic process | 8 out of 47 genes, 17.0% | 148 out of 533 genes, 27.8% | 0.9753351 |
| regulation of biosynthetic process | 5 out of 47 genes, 10.6% | 108 out of 533 genes, 20.3% | 0.9785777 |
| regulation of transcription, DNA-dependent | 3 out of 47 genes, 6.4% | 82 out of 533 genes, 15.4% | 0.9857807 |
| cellular protein metabolic process | 7 out of 47 genes, 14.9% | 143 out of 533 genes, 26.8% | 0.9865153 |
| regulation of RNA biosynthetic process | 3 out of 47 genes, 6.4% | 84 out of 533 genes, 15.8% | 0.9879812 |
| regulation of macromolecule metabolic process | 7 out of 47 genes, 14.9% | 146 out of 533 genes, 27.4% | 0.9891828 |
| regulation of macromolecule biosynthetic process | 4 out of 47 genes, 8.5% | 103 out of 533 genes, 19.3% | 0.9903567 |
| regulation of cellular biosynthetic process | 4 out of 47 genes, 8.5% | 105 out of 533 genes, 19.7% | 0.9918191 |
| regulation of RNA metabolic process | 3 out of 47 genes, 6.4% | 92 out of 533 genes, 17.3% | 0.9939766 |
| regulation of nucleobase-containing compound metabolic process | 4 out of 47 genes, 8.5% | 111 out of 533 genes, 20.8% | 0.9950621 |
| regulation of nitrogen compound metabolic process | 4 out of 47 genes, 8.5% | 115 out of 533 genes, 21.6% | 0.9965063 |
| regulation of cellular macromolecule biosynthetic process | 3 out of 47 genes, 6.4% | 99 out of 533 genes, 18.6% | 0.9967848 |
| regulation of gene expression | 4 out of 47 genes, 8.5% | 116 out of 533 genes, 21.8% | 0.9967995 |
| Gene Ontology term | Genes annotated to the term |
|---|
| muscle cell development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| striated muscle cell development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| muscle organ development | ENSAPLP00000003657, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| cellular component organization | ENSAPLP00000013416, ENSAPLP00000009873, ENSAPLP00000008674, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000008118, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000007755, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000008212, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000013090, ENSAPLP00000011602, ENSAPLP00000010726, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000002091 |
| myofibril assembly | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| actomyosin structure organization | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin-myosin filament sliding | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| actin-mediated cell contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| striated muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| muscle structure development | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| cellular component organization or biogenesis | ENSAPLP00000013416, ENSAPLP00000009873, ENSAPLP00000008674, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000008118, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000007755, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000008212, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000013090, ENSAPLP00000011602, ENSAPLP00000010726, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000002091 |
| single-organism process | ENSAPLP00000013416, ENSAPLP00000009873, ENSAPLP00000008674, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000009308, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000011711, ENSAPLP00000005038, ENSAPLP00000015089, ENSAPLP00000014548, ENSAPLP00000011602, ENSAPLP00000010726, ENSAPLP00000003219, ENSAPLP00000013787, ENSAPLP00000016219, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000015793, ENSAPLP00000008118, ENSAPLP00000009880, ENSAPLP00000002553, ENSAPLP00000008210, ENSAPLP00000015679, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000001762, ENSAPLP00000013090, ENSAPLP00000004030, ENSAPLP00000011900, ENSAPLP00000000447, ENSAPLP00000002091 |
| muscle system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| striated muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| cellular component movement | ENSAPLP00000003657, ENSAPLP00000008674, ENSAPLP00000015089, ENSAPLP00000004050, ENSAPLP00000009880, ENSAPLP00000011602, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000002381 |
| muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| actin filament-based process | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000014548, ENSAPLP00000002381 |
| muscle filament sliding | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000015089 |
| muscle organ morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal muscle fiber development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000002381 |
| muscle fiber development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000002381 |
| cardiac muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| actin filament-based movement | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| actin cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000014548, ENSAPLP00000002381 |
| extracellular matrix organization | ENSAPLP00000013972, ENSAPLP00000009873, ENSAPLP00000003689, ENSAPLP00000006049, ENSAPLP00000008118 |
| extracellular structure organization | ENSAPLP00000013972, ENSAPLP00000009873, ENSAPLP00000003689, ENSAPLP00000006049, ENSAPLP00000008118 |
| cellular component assembly involved in morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| locomotion | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000008674, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000004050, ENSAPLP00000008118, ENSAPLP00000013090 |
| cell development | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| heart process | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal muscle tissue development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000002381 |
| blood circulation | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| innate immune response | ENSAPLP00000007755, ENSAPLP00000005038, ENSAPLP00000006873 |
| heart contraction | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal muscle organ development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000002381 |
| cellular component morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| single-organism cellular process | ENSAPLP00000013416, ENSAPLP00000009873, ENSAPLP00000008674, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000009308, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015089, ENSAPLP00000014548, ENSAPLP00000011602, ENSAPLP00000010726, ENSAPLP00000003219, ENSAPLP00000013787, ENSAPLP00000016219, ENSAPLP00000003689, ENSAPLP00000015793, ENSAPLP00000008118, ENSAPLP00000004050, ENSAPLP00000009880, ENSAPLP00000008210, ENSAPLP00000015679, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000001762, ENSAPLP00000013090, ENSAPLP00000000447, ENSAPLP00000002091 |
| regulation of biological quality | ENSAPLP00000003372, ENSAPLP00000016219, ENSAPLP00000001720, ENSAPLP00000004050, ENSAPLP00000001762, ENSAPLP00000013090, ENSAPLP00000009880, ENSAPLP00000015679, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000002091, ENSAPLP00000002381 |
| leukocyte mediated immunity | ENSAPLP00000007755, ENSAPLP00000006873, ENSAPLP00000002091 |
| regulation of muscle contraction | ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000013090 |
| actin filament organization | ENSAPLP00000003657, ENSAPLP00000014548, ENSAPLP00000002381 |
| cytoskeleton organization | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000014548, ENSAPLP00000002381 |
| immune response | ENSAPLP00000007755, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000002091 |
| cell killing | ENSAPLP00000007755, ENSAPLP00000006873 |
| leukocyte mediated cytotoxicity | ENSAPLP00000007755, ENSAPLP00000006873 |
| natural killer cell mediated immunity | ENSAPLP00000007755, ENSAPLP00000006873 |
| striated muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| regulation of blood pressure | ENSAPLP00000003219, ENSAPLP00000002381 |
| skeletal myofibril assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| skeletal muscle thin filament assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiocyte differentiation | ENSAPLP00000003657, ENSAPLP00000002381 |
| natural killer cell mediated cytotoxicity | ENSAPLP00000007755, ENSAPLP00000006873 |
| sarcomere organization | ENSAPLP00000009880, ENSAPLP00000003219 |
| cardiac myofibril assembly | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac cell development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle cell differentiation | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle cell development | ENSAPLP00000003657, ENSAPLP00000002381 |
| cardiac muscle contraction | ENSAPLP00000003657, ENSAPLP00000003219 |
| regulation of muscle system process | ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000013090 |
| chemotaxis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000004050, ENSAPLP00000008118, ENSAPLP00000013090 |
| taxis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000004050, ENSAPLP00000008118, ENSAPLP00000013090 |
| response to external stimulus | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000004050, ENSAPLP00000008118, ENSAPLP00000013090 |
| organelle organization | ENSAPLP00000003657, ENSAPLP00000003372, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000007755, ENSAPLP00000002091, ENSAPLP00000002381 |
| macromolecular complex subunit organization | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000013416, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000015793, ENSAPLP00000011602, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000002381 |
| immune effector process | ENSAPLP00000007755, ENSAPLP00000006873, ENSAPLP00000002091 |
| lymphocyte mediated immunity | ENSAPLP00000007755, ENSAPLP00000006873 |
| regulation of heart contraction | ENSAPLP00000003219, ENSAPLP00000012915 |
| response to temperature stimulus | ENSAPLP00000000447, ENSAPLP00000004050 |
| response to heat | ENSAPLP00000000447, ENSAPLP00000004050 |
| fertilization | ENSAPLP00000011900, ENSAPLP00000011529 |
| cell projection organization | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000008118, ENSAPLP00000013090 |
| system process | ENSAPLP00000003657, ENSAPLP00000006303, ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| anatomical structure formation involved in morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| system development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002381 |
| axon guidance | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000008118, ENSAPLP00000013090 |
| cardiovascular system development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| circulatory system development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| response to abiotic stimulus | ENSAPLP00000003657, ENSAPLP00000000447, ENSAPLP00000005411, ENSAPLP00000004050, ENSAPLP00000014548 |
| protein complex subunit organization | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000015793, ENSAPLP00000011602, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000002381 |
| wound healing | ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000001762, ENSAPLP00000002091 |
| regulation of system process | ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000012915, ENSAPLP00000013090 |
| neuron differentiation | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000007755, ENSAPLP00000008118, ENSAPLP00000013090 |
| cation transport | ENSAPLP00000015679, ENSAPLP00000009300, ENSAPLP00000002091 |
| heart development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| tissue morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| homeostatic process | ENSAPLP00000015679, ENSAPLP00000003372, ENSAPLP00000016219, ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000006873 |
| G2/M transition of mitotic cell cycle | ENSAPLP00000000447, ENSAPLP00000007755 |
| cellular response to oxidative stress | ENSAPLP00000003219, ENSAPLP00000006873 |
| cellular response to reactive oxygen species | ENSAPLP00000003219, ENSAPLP00000006873 |
| ribosomal small subunit biogenesis | ENSAPLP00000003372, ENSAPLP00000015793 |
| response to wounding | ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000005038, ENSAPLP00000001762, ENSAPLP00000002091 |
| defense response | ENSAPLP00000007755, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000002091 |
| axonogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000008118, ENSAPLP00000013090 |
| neuron projection development | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000008118, ENSAPLP00000013090 |
| cell morphogenesis involved in neuron differentiation | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000008118, ENSAPLP00000013090 |
| neuron projection morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000008118, ENSAPLP00000013090 |
| cell motility | ENSAPLP00000008674, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000004050 |
| localization of cell | ENSAPLP00000008674, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000004050 |
| anatomical structure morphogenesis | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000002381 |
| cell differentiation | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002381 |
| multicellular organismal process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000015089, ENSAPLP00000001762, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002091, ENSAPLP00000002381 |
| DNA packaging | ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001762 |
| tissue development | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| response to stress | ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000004050, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000007755, ENSAPLP00000006873, ENSAPLP00000002091 |
| spindle organization | ENSAPLP00000013416, ENSAPLP00000007755 |
| sexual reproduction | ENSAPLP00000013416, ENSAPLP00000011900, ENSAPLP00000011529 |
| DNA conformation change | ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001762 |
| cell morphogenesis involved in differentiation | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000008118, ENSAPLP00000013090 |
| single-multicellular organism process | ENSAPLP00000003657, ENSAPLP00000015089, ENSAPLP00000001762, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002091, ENSAPLP00000002381 |
| cellular developmental process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002381 |
| neuron development | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000008118, ENSAPLP00000013090 |
| cellular response to oxygen-containing compound | ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000014548, ENSAPLP00000008118 |
| neurogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000007755, ENSAPLP00000008118, ENSAPLP00000013090 |
| generation of neurons | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000007755, ENSAPLP00000008118, ENSAPLP00000013090 |
| response to oxygen-containing compound | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000014548, ENSAPLP00000008118 |
| blood coagulation | ENSAPLP00000009880, ENSAPLP00000001762, ENSAPLP00000002091 |
| hemostasis | ENSAPLP00000009880, ENSAPLP00000001762, ENSAPLP00000002091 |
| response to inorganic substance | ENSAPLP00000003657, ENSAPLP00000009880, ENSAPLP00000006873 |
| coagulation | ENSAPLP00000009880, ENSAPLP00000001762, ENSAPLP00000002091 |
| response to chemical stimulus | ENSAPLP00000003657, ENSAPLP00000004050, ENSAPLP00000014548, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000002091 |
| cell part morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000008118, ENSAPLP00000013090 |
| cell projection morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000008118, ENSAPLP00000013090 |
| response to reactive oxygen species | ENSAPLP00000003219, ENSAPLP00000006873 |
| ATP catabolic process | ENSAPLP00000003657, ENSAPLP00000009300 |
| negative regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of actin filament polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| erythrocyte homeostasis | ENSAPLP00000003372, ENSAPLP00000006873 |
| cell cycle phase transition | ENSAPLP00000000447, ENSAPLP00000007755 |
| mitotic cell cycle phase transition | ENSAPLP00000000447, ENSAPLP00000007755 |
| actin filament capping | ENSAPLP00000003219, ENSAPLP00000004050 |
| response to stimulus | ENSAPLP00000013416, ENSAPLP00000004050, ENSAPLP00000008118, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000007755, ENSAPLP00000006873, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000009308, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000001762, ENSAPLP00000014548, ENSAPLP00000013090, ENSAPLP00000004030, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000002091 |
| ion transport | ENSAPLP00000015679, ENSAPLP00000009300, ENSAPLP00000002091 |
| organ morphogenesis | ENSAPLP00000003657, ENSAPLP00000003219, ENSAPLP00000002381 |
| single organism reproductive process | ENSAPLP00000013416, ENSAPLP00000011900, ENSAPLP00000011529 |
| regulation of anatomical structure size | ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000002381 |
| cellular component assembly | ENSAPLP00000003372, ENSAPLP00000008674, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000009880, ENSAPLP00000011602, ENSAPLP00000007755 |
| anatomical structure development | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002381 |
| single-organism developmental process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular macromolecular complex assembly | ENSAPLP00000011602, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000007755, ENSAPLP00000001762 |
| protein targeting | ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| regulation of body fluid levels | ENSAPLP00000009880, ENSAPLP00000001762, ENSAPLP00000002091 |
| cell morphogenesis | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000008118, ENSAPLP00000013090 |
| inflammatory response | ENSAPLP00000005038, ENSAPLP00000002091 |
| response to metal ion | ENSAPLP00000003657, ENSAPLP00000009880 |
| regulation of actin filament depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| negative regulation of protein polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| cell junction assembly | ENSAPLP00000009880, ENSAPLP00000008674 |
| response to drug | ENSAPLP00000003657, ENSAPLP00000002091 |
| negative regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| protein polymerization | ENSAPLP00000011602, ENSAPLP00000007755 |
| organelle assembly | ENSAPLP00000003372, ENSAPLP00000007755 |
| negative regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of multicellular organismal process | ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015089, ENSAPLP00000004050, ENSAPLP00000012915, ENSAPLP00000013090 |
| organ development | ENSAPLP00000003657, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000008118, ENSAPLP00000002381 |
| viral infectious cycle | ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000015793 |
| M phase | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000007755 |
| cell migration | ENSAPLP00000008674, ENSAPLP00000007755, ENSAPLP00000004050 |
| regulation of cell migration | ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of locomotion | ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| regulation of cell motility | ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| cellular component biogenesis | ENSAPLP00000003372, ENSAPLP00000008674, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000011602, ENSAPLP00000007755 |
| cellular process involved in reproduction | ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000000447, ENSAPLP00000015793 |
| cellular nitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000009300, ENSAPLP00000007755, ENSAPLP00000009975 |
| heterocycle catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000009300, ENSAPLP00000007755, ENSAPLP00000009975 |
| organic cyclic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000009300, ENSAPLP00000007755, ENSAPLP00000009975 |
| intracellular protein transport | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| blood vessel development | ENSAPLP00000008118, ENSAPLP00000002381 |
| vasculature development | ENSAPLP00000008118, ENSAPLP00000002381 |
| response to oxidative stress | ENSAPLP00000003219, ENSAPLP00000006873 |
| negative regulation of protein complex assembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| homeostasis of number of cells | ENSAPLP00000003372, ENSAPLP00000006873 |
| negative regulation of cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| anatomical structure homeostasis | ENSAPLP00000016219, ENSAPLP00000001720 |
| regulation of protein depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| multicellular organismal development | ENSAPLP00000003657, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002381 |
| regulation of cellular component movement | ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000005411 |
| protein transport | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| translational elongation | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000010726, ENSAPLP00000015793 |
| establishment of protein localization | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| cellular catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000014548, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000006873, ENSAPLP00000009300, ENSAPLP00000009975 |
| nucleosome assembly | ENSAPLP00000001720, ENSAPLP00000001762 |
| negative regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of actin filament polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| chromatin assembly | ENSAPLP00000001720, ENSAPLP00000001762 |
| cell junction organization | ENSAPLP00000009880, ENSAPLP00000008674 |
| regulation of protein complex disassembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| cellular protein complex assembly | ENSAPLP00000011602, ENSAPLP00000007755 |
| ATP metabolic process | ENSAPLP00000003657, ENSAPLP00000009300 |
| organic hydroxy compound metabolic process | ENSAPLP00000010846, ENSAPLP00000012915 |
| single-organism transport | ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000011711, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000015679, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002091 |
| biological regulation | ENSAPLP00000013416, ENSAPLP00000016219, ENSAPLP00000004050, ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000013972, ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000012915, ENSAPLP00000006049, ENSAPLP00000002381, ENSAPLP00000009308, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015089, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000013090, ENSAPLP00000004030, ENSAPLP00000004471, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002091 |
| protein targeting to membrane | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793, ENSAPLP00000013090 |
| reproduction | ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000011900, ENSAPLP00000010726, ENSAPLP00000000447, ENSAPLP00000011529, ENSAPLP00000015793 |
| nervous system development | ENSAPLP00000009880, ENSAPLP00000006303, ENSAPLP00000007755, ENSAPLP00000008118, ENSAPLP00000013090 |
| protein localization to organelle | ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000002091, ENSAPLP00000015793 |
| nuclear-transcribed mRNA catabolic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000014331, ENSAPLP00000015793 |
| chromosome organization | ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000001720, ENSAPLP00000001762 |
| establishment of protein localization to organelle | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000002091, ENSAPLP00000015793 |
| regulation of response to stress | ENSAPLP00000006303, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873 |
| nucleobase-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000014331, ENSAPLP00000009300, ENSAPLP00000015793 |
| nuclear division | ENSAPLP00000013416, ENSAPLP00000007755 |
| chromatin assembly or disassembly | ENSAPLP00000001720, ENSAPLP00000001762 |
| mitosis | ENSAPLP00000013416, ENSAPLP00000007755 |
| regulation of actin polymerization or depolymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| positive regulation of cell migration | ENSAPLP00000013972, ENSAPLP00000005411 |
| regulation of actin filament length | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of protein polymerization | ENSAPLP00000003219, ENSAPLP00000004050 |
| nucleosome organization | ENSAPLP00000001720, ENSAPLP00000001762 |
| positive regulation of locomotion | ENSAPLP00000013972, ENSAPLP00000005411 |
| organelle fission | ENSAPLP00000013416, ENSAPLP00000007755 |
| protein-DNA complex assembly | ENSAPLP00000001720, ENSAPLP00000001762 |
| positive regulation of cell motility | ENSAPLP00000013972, ENSAPLP00000005411 |
| aromatic compound catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000014331, ENSAPLP00000009300, ENSAPLP00000015793 |
| RNA catabolic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000014331, ENSAPLP00000015793 |
| mRNA catabolic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000014331, ENSAPLP00000015793 |
| cellular component disassembly | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000000447, ENSAPLP00000015793 |
| immune system process | ENSAPLP00000006303, ENSAPLP00000007755, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000002091 |
| cellular response to chemical stimulus | ENSAPLP00000006303, ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000004050, ENSAPLP00000014548, ENSAPLP00000008118 |
| M phase of mitotic cell cycle | ENSAPLP00000013416, ENSAPLP00000007755 |
| microtubule cytoskeleton organization | ENSAPLP00000013416, ENSAPLP00000007755 |
| regulation of cytokine production | ENSAPLP00000005038, ENSAPLP00000004050 |
| rRNA processing | ENSAPLP00000003372, ENSAPLP00000015793 |
| rRNA metabolic process | ENSAPLP00000003372, ENSAPLP00000015793 |
| regulation of actin cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of actin filament-based process | ENSAPLP00000003219, ENSAPLP00000004050 |
| positive regulation of multicellular organismal process | ENSAPLP00000003219, ENSAPLP00000004050 |
| positive regulation of cellular component movement | ENSAPLP00000013972, ENSAPLP00000005411 |
| protein-DNA complex subunit organization | ENSAPLP00000001720, ENSAPLP00000001762 |
| cellular process | ENSAPLP00000013416, ENSAPLP00000009873, ENSAPLP00000014148, ENSAPLP00000008674, ENSAPLP00000014331, ENSAPLP00000006303, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000009975, ENSAPLP00000009308, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015089, ENSAPLP00000014548, ENSAPLP00000011602, ENSAPLP00000010726, ENSAPLP00000003219, ENSAPLP00000013787, ENSAPLP00000016219, ENSAPLP00000003689, ENSAPLP00000004050, ENSAPLP00000015793, ENSAPLP00000008118, ENSAPLP00000009880, ENSAPLP00000008210, ENSAPLP00000015679, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000006049, ENSAPLP00000012915, ENSAPLP00000002381, ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000001762, ENSAPLP00000013090, ENSAPLP00000004030, ENSAPLP00000000447, ENSAPLP00000002091 |
| cell adhesion | ENSAPLP00000008210, ENSAPLP00000013787, ENSAPLP00000003689, ENSAPLP00000006049 |
| biological adhesion | ENSAPLP00000008210, ENSAPLP00000013787, ENSAPLP00000003689, ENSAPLP00000006049 |
| cellular protein localization | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| cellular macromolecule localization | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| reproductive process | ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000011900, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000015793 |
| macromolecular complex assembly | ENSAPLP00000011602, ENSAPLP00000003372, ENSAPLP00000001720, ENSAPLP00000007755, ENSAPLP00000005038, ENSAPLP00000001762 |
| organonitrogen compound catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000009975 |
| translational termination | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| lipid metabolic process | ENSAPLP00000010846, ENSAPLP00000011529, ENSAPLP00000005038 |
| microtubule-based process | ENSAPLP00000011602, ENSAPLP00000013416, ENSAPLP00000007755 |
| viral genome expression | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| viral transcription | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| cellular homeostasis | ENSAPLP00000015679, ENSAPLP00000016219 |
| regulation of cellular component size | ENSAPLP00000003219, ENSAPLP00000004050 |
| catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000014548, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000006873, ENSAPLP00000009300, ENSAPLP00000009975 |
| regulation of localization | ENSAPLP00000013972, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873 |
| developmental process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000008118, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000009880, ENSAPLP00000003219, ENSAPLP00000007755, ENSAPLP00000002381 |
| localization | ENSAPLP00000009308, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000008674, ENSAPLP00000011711, ENSAPLP00000004050, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000015679, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002091 |
| chromatin organization | ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001762 |
| protein complex disassembly | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| cellular protein complex disassembly | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| viral reproduction | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000015793 |
| multi-organism cellular process | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000015793 |
| protein localization | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| organic substance transport | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| microtubule-based movement | ENSAPLP00000011602, ENSAPLP00000007755 |
| regulation of I-kappaB kinase/NF-kappaB cascade | ENSAPLP00000006873, ENSAPLP00000004050 |
| cellular response to organic nitrogen | ENSAPLP00000014548, ENSAPLP00000008118 |
| nitrogen compound transport | ENSAPLP00000013416, ENSAPLP00000002091 |
| purine nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine nucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine ribonucleoside triphosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine ribonucleoside catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| glycosyl compound catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| cell cycle phase | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000007755 |
| macromolecular complex disassembly | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| multi-organism process | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000015793, ENSAPLP00000002381 |
| purine nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| DNA metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000001762 |
| purine ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| ribonucleotide catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| organophosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine-containing compound catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleoside phosphate catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| response to organic cyclic compound | ENSAPLP00000003657, ENSAPLP00000014548 |
| cellular lipid metabolic process | ENSAPLP00000011529, ENSAPLP00000005038 |
| small molecule biosynthetic process | ENSAPLP00000005038, ENSAPLP00000012915 |
| positive regulation of transport | ENSAPLP00000005411, ENSAPLP00000005038 |
| negative regulation of developmental process | ENSAPLP00000001720, ENSAPLP00000005038 |
| regulation of protein transport | ENSAPLP00000005038, ENSAPLP00000006873 |
| cell division | ENSAPLP00000013416, ENSAPLP00000007755 |
| cellular response to nitrogen compound | ENSAPLP00000014548, ENSAPLP00000008118 |
| mitotic cell cycle | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000007755 |
| cotranslational protein targeting to membrane | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| SRP-dependent cotranslational protein targeting to membrane | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| negative regulation of signal transduction | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000005038 |
| protein targeting to ER | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| protein localization to endoplasmic reticulum | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| establishment of protein localization to endoplasmic reticulum | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| transport | ENSAPLP00000009308, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000011711, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000015679, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002091 |
| carbohydrate derivative catabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| intracellular transport | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| organic substance catabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000014331, ENSAPLP00000014548, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000009975 |
| establishment of localization | ENSAPLP00000009308, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000011711, ENSAPLP00000015793, ENSAPLP00000013090, ENSAPLP00000006303, ENSAPLP00000015679, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002091 |
| cell-cell signaling | ENSAPLP00000006303, ENSAPLP00000002091 |
| ncRNA processing | ENSAPLP00000003372, ENSAPLP00000015793 |
| regulation of protein complex assembly | ENSAPLP00000003219, ENSAPLP00000004050 |
| single-organism biosynthetic process | ENSAPLP00000005038, ENSAPLP00000012915 |
| negative regulation of cellular component organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of establishment of protein localization | ENSAPLP00000005038, ENSAPLP00000006873 |
| regulation of cellular response to stress | ENSAPLP00000005038, ENSAPLP00000006873 |
| regulation of signal transduction | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000004050, ENSAPLP00000006049 |
| regulation of immune system process | ENSAPLP00000006303, ENSAPLP00000001720, ENSAPLP00000005038 |
| negative regulation of cell communication | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000005038 |
| negative regulation of signaling | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000005038 |
| regulation of hydrolase activity | ENSAPLP00000012216, ENSAPLP00000003219, ENSAPLP00000014548 |
| viral reproductive process | ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000015793 |
| regulation of developmental process | ENSAPLP00000011529, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000013090 |
| chromatin modification | ENSAPLP00000012216, ENSAPLP00000001720 |
| regulation of cytoskeleton organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| response to growth factor stimulus | ENSAPLP00000006303, ENSAPLP00000004050 |
| cellular response to growth factor stimulus | ENSAPLP00000006303, ENSAPLP00000004050 |
| multi-organism reproductive process | ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000015793 |
| establishment of localization in cell | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| regulation of response to stimulus | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000004050, ENSAPLP00000006049 |
| apoptotic process | ENSAPLP00000003657, ENSAPLP00000002381 |
| programmed cell death | ENSAPLP00000003657, ENSAPLP00000002381 |
| negative regulation of apoptotic process | ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of cellular component biogenesis | ENSAPLP00000003219, ENSAPLP00000004050 |
| chemical homeostasis | ENSAPLP00000015679, ENSAPLP00000011529 |
| macromolecule localization | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| translational initiation | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| response to endogenous stimulus | ENSAPLP00000003657, ENSAPLP00000014548, ENSAPLP00000008118 |
| negative regulation of response to stimulus | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000005038 |
| cytoplasmic transport | ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000002091, ENSAPLP00000015793 |
| purine nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| cellular response to organic substance | ENSAPLP00000006303, ENSAPLP00000004050, ENSAPLP00000014548, ENSAPLP00000008118 |
| translation | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000010726, ENSAPLP00000014148, ENSAPLP00000015793 |
| ribonucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| protein complex assembly | ENSAPLP00000011602, ENSAPLP00000007755, ENSAPLP00000005038 |
| protein folding | ENSAPLP00000009880, ENSAPLP00000014548 |
| cell death | ENSAPLP00000003657, ENSAPLP00000002381 |
| response to organic nitrogen | ENSAPLP00000014548, ENSAPLP00000008118 |
| death | ENSAPLP00000003657, ENSAPLP00000002381 |
| ribosome biogenesis | ENSAPLP00000003372, ENSAPLP00000015793 |
| negative regulation of programmed cell death | ENSAPLP00000005038, ENSAPLP00000004050 |
| negative regulation of cell death | ENSAPLP00000005038, ENSAPLP00000004050 |
| macromolecule catabolic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000014331, ENSAPLP00000014548, ENSAPLP00000015793 |
| organic cyclic compound metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001762, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000010846, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000002091, ENSAPLP00000009975 |
| nucleoside triphosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| protein complex biogenesis | ENSAPLP00000011602, ENSAPLP00000007755, ENSAPLP00000005038 |
| response to organic substance | ENSAPLP00000003657, ENSAPLP00000006303, ENSAPLP00000004050, ENSAPLP00000014548, ENSAPLP00000008118 |
| positive regulation of protein phosphorylation | ENSAPLP00000000447, ENSAPLP00000005038 |
| ribonucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| regulation of phosphate metabolic process | ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000005038, ENSAPLP00000014548 |
| regulation of phosphorus metabolic process | ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000005038, ENSAPLP00000014548 |
| cellular response to stimulus | ENSAPLP00000009308, ENSAPLP00000013416, ENSAPLP00000001720, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000004050, ENSAPLP00000014548, ENSAPLP00000008118, ENSAPLP00000006303, ENSAPLP00000003219, ENSAPLP00000006873, ENSAPLP00000002091 |
| purine nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleoside metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| purine-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| glycosyl compound metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| regulation of cell communication | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000004050, ENSAPLP00000006049 |
| cellular membrane organization | ENSAPLP00000006303, ENSAPLP00000013090 |
| regulation of protein localization | ENSAPLP00000005038, ENSAPLP00000006873 |
| positive regulation of phosphorylation | ENSAPLP00000000447, ENSAPLP00000005038 |
| membrane organization | ENSAPLP00000006303, ENSAPLP00000013090 |
| organonitrogen compound biosynthetic process | ENSAPLP00000009300, ENSAPLP00000012915 |
| response to nitrogen compound | ENSAPLP00000014548, ENSAPLP00000008118 |
| cellular aromatic compound metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001762, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000002091, ENSAPLP00000009975 |
| nucleobase-containing small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000009975 |
| regulation of intracellular protein kinase cascade | ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000004050 |
| regulation of signaling | ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000005038, ENSAPLP00000006873, ENSAPLP00000004050, ENSAPLP00000006049 |
| ribonucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| ribose phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| ncRNA metabolic process | ENSAPLP00000003372, ENSAPLP00000015793 |
| cellular response to endogenous stimulus | ENSAPLP00000014548, ENSAPLP00000008118 |
| cellular localization | ENSAPLP00000006303, ENSAPLP00000008212, ENSAPLP00000013416, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000002091, ENSAPLP00000015793, ENSAPLP00000013090 |
| nucleic acid metabolic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001762, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000002091 |
| cell cycle process | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000007755 |
| organonitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000009975 |
| positive regulation of phosphorus metabolic process | ENSAPLP00000000447, ENSAPLP00000005038 |
| regulation of organelle organization | ENSAPLP00000003219, ENSAPLP00000004050 |
| regulation of MAPK cascade | ENSAPLP00000005038, ENSAPLP00000006873 |
| positive regulation of phosphate metabolic process | ENSAPLP00000000447, ENSAPLP00000005038 |
| aromatic compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000015793 |
| regulation of cell death | ENSAPLP00000013972, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of apoptotic process | ENSAPLP00000013972, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of programmed cell death | ENSAPLP00000013972, ENSAPLP00000005038, ENSAPLP00000004050 |
| cellular macromolecule catabolic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000014331, ENSAPLP00000014548, ENSAPLP00000015793 |
| regulation of cellular localization | ENSAPLP00000005038, ENSAPLP00000006873 |
| small molecule metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000010846, ENSAPLP00000007755, ENSAPLP00000005038, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000009975 |
| nucleobase-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001762, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002091, ENSAPLP00000009975 |
| regulation of transport | ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000006873 |
| positive regulation of protein metabolic process | ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000004050 |
| small GTPase mediated signal transduction | ENSAPLP00000009308, ENSAPLP00000013416 |
| regulation of cell differentiation | ENSAPLP00000011529, ENSAPLP00000001720 |
| RNA biosynthetic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000015793 |
| organic cyclic compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000015793 |
| regulation of protein phosphorylation | ENSAPLP00000000447, ENSAPLP00000005038 |
| ribonucleoprotein complex biogenesis | ENSAPLP00000003372, ENSAPLP00000015793 |
| regulation of cell cycle | ENSAPLP00000000447, ENSAPLP00000005038 |
| nitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001762, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000002091, ENSAPLP00000009975 |
| nucleoside phosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| nucleotide metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| carbohydrate derivative metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| heterocycle metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001762, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002091, ENSAPLP00000009975 |
| regulation of catalytic activity | ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000014548 |
| single-organism metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000005038, ENSAPLP00000011529, ENSAPLP00000010846, ENSAPLP00000009300, ENSAPLP00000007755, ENSAPLP00000009975, ENSAPLP00000012915 |
| cell cycle | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000007755 |
| cellular response to stress | ENSAPLP00000003219, ENSAPLP00000005411, ENSAPLP00000006873 |
| GTP catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| guanosine-containing compound catabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| cellular biosynthetic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000005038, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000012915 |
| organophosphate metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| mRNA metabolic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000014331, ENSAPLP00000002091, ENSAPLP00000015793 |
| regulation of molecular function | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000014548 |
| cellular nitrogen compound metabolic process | ENSAPLP00000003657, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000001762, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000002091, ENSAPLP00000009975 |
| macromolecule biosynthetic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000010726, ENSAPLP00000014148, ENSAPLP00000011529, ENSAPLP00000015793 |
| cellular macromolecule biosynthetic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000010726, ENSAPLP00000014148, ENSAPLP00000011529, ENSAPLP00000015793 |
| positive regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000005038 |
| regulation of phosphorylation | ENSAPLP00000000447, ENSAPLP00000005038 |
| regulation of biological process | ENSAPLP00000013416, ENSAPLP00000016219, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000012915, ENSAPLP00000006049, ENSAPLP00000009308, ENSAPLP00000012216, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000015089, ENSAPLP00000014548, ENSAPLP00000013090, ENSAPLP00000004471, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000002091 |
| nucleobase-containing compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000009300, ENSAPLP00000015793 |
| organic acid metabolic process | ENSAPLP00000005038, ENSAPLP00000012915 |
| carboxylic acid metabolic process | ENSAPLP00000005038, ENSAPLP00000012915 |
| oxoacid metabolic process | ENSAPLP00000005038, ENSAPLP00000012915 |
| organic substance biosynthetic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000005038, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000012915 |
| positive regulation of cellular process | ENSAPLP00000013972, ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000004050 |
| positive regulation of molecular function | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000003219 |
| GTP metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| guanosine-containing compound metabolic process | ENSAPLP00000013416, ENSAPLP00000007755 |
| biosynthetic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000005038, ENSAPLP00000015793, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000012915 |
| heterocycle biosynthetic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000009300, ENSAPLP00000015793 |
| cellular nitrogen compound biosynthetic process | ENSAPLP00000008212, ENSAPLP00000010726, ENSAPLP00000009300, ENSAPLP00000015793 |
| protein catabolic process | ENSAPLP00000011529, ENSAPLP00000014548 |
| positive regulation of cellular protein metabolic process | ENSAPLP00000000447, ENSAPLP00000005038 |
| regulation of cellular component organization | ENSAPLP00000003219, ENSAPLP00000004050, ENSAPLP00000013090 |
| negative regulation of cellular process | ENSAPLP00000002553, ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000004050 |
| negative regulation of gene expression | ENSAPLP00000002553, ENSAPLP00000005038 |
| regulation of protein metabolic process | ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000004050 |
| RNA metabolic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000010726, ENSAPLP00000014331, ENSAPLP00000002091, ENSAPLP00000015793 |
| positive regulation of catalytic activity | ENSAPLP00000000447, ENSAPLP00000003219 |
| RNA processing | ENSAPLP00000003372, ENSAPLP00000014331, ENSAPLP00000015793 |
| vesicle-mediated transport | ENSAPLP00000006303, ENSAPLP00000002091 |
| regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000005038 |
| intracellular signal transduction | ENSAPLP00000009308, ENSAPLP00000013416, ENSAPLP00000001720 |
| positive regulation of biological process | ENSAPLP00000013972, ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000005411, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of cellular process | ENSAPLP00000013416, ENSAPLP00000016219, ENSAPLP00000004050, ENSAPLP00000006303, ENSAPLP00000002553, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000006873, ENSAPLP00000006049, ENSAPLP00000009308, ENSAPLP00000005411, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000013090, ENSAPLP00000004471, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000002091 |
| positive regulation of response to stimulus | ENSAPLP00000005411, ENSAPLP00000005038 |
| gene expression | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000010726, ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000002091, ENSAPLP00000015793 |
| negative regulation of biological process | ENSAPLP00000002553, ENSAPLP00000004471, ENSAPLP00000006303, ENSAPLP00000003219, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000004050 |
| positive regulation of cellular metabolic process | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000004050 |
| positive regulation of macromolecule metabolic process | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000004050 |
| signal transduction | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002091 |
| proteolysis | ENSAPLP00000013972, ENSAPLP00000014548 |
| positive regulation of macromolecule biosynthetic process | ENSAPLP00000013416, ENSAPLP00000004050 |
| phosphorus metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| phosphate-containing compound metabolic process | ENSAPLP00000003657, ENSAPLP00000013416, ENSAPLP00000007755, ENSAPLP00000009300 |
| positive regulation of metabolic process | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000005038, ENSAPLP00000004050 |
| signaling | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002091 |
| single organism signaling | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002091 |
| positive regulation of cellular biosynthetic process | ENSAPLP00000013416, ENSAPLP00000004050 |
| positive regulation of biosynthetic process | ENSAPLP00000013416, ENSAPLP00000004050 |
| cell communication | ENSAPLP00000009308, ENSAPLP00000006303, ENSAPLP00000013416, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000002091 |
| primary metabolic process | ENSAPLP00000013416, ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000009975, ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000008212, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000010726, ENSAPLP00000010846, ENSAPLP00000002091 |
| regulation of primary metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000016219, ENSAPLP00000005038, ENSAPLP00000004050, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000011529 |
| regulation of cellular protein metabolic process | ENSAPLP00000000447, ENSAPLP00000005038 |
| negative regulation of macromolecule metabolic process | ENSAPLP00000002553, ENSAPLP00000005038 |
| regulation of metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000016219, ENSAPLP00000005038, ENSAPLP00000004050, ENSAPLP00000014548, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000011529 |
| cellular metabolic process | ENSAPLP00000013416, ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000006873, ENSAPLP00000012915, ENSAPLP00000009975, ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000008212, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000010726, ENSAPLP00000002091 |
| cellular macromolecule metabolic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000014148, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000002091 |
| negative regulation of metabolic process | ENSAPLP00000002553, ENSAPLP00000005038 |
| macromolecule metabolic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000014148, ENSAPLP00000001720, ENSAPLP00000014331, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000013972, ENSAPLP00000010726, ENSAPLP00000011529, ENSAPLP00000002091 |
| metabolic process | ENSAPLP00000013416, ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000006873, ENSAPLP00000012915, ENSAPLP00000009975, ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000008212, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000010726, ENSAPLP00000010846, ENSAPLP00000002091 |
| organic substance metabolic process | ENSAPLP00000013416, ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000013972, ENSAPLP00000011529, ENSAPLP00000007755, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000009975, ENSAPLP00000003657, ENSAPLP00000012216, ENSAPLP00000003372, ENSAPLP00000008212, ENSAPLP00000001720, ENSAPLP00000005038, ENSAPLP00000014548, ENSAPLP00000001762, ENSAPLP00000010726, ENSAPLP00000010846, ENSAPLP00000002091 |
| protein metabolic process | ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000014148, ENSAPLP00000014548, ENSAPLP00000015793, ENSAPLP00000009880, ENSAPLP00000013972, ENSAPLP00000010726, ENSAPLP00000011529 |
| cell surface receptor signaling pathway | ENSAPLP00000006303, ENSAPLP00000005038 |
| regulation of cellular metabolic process | ENSAPLP00000013416, ENSAPLP00000016219, ENSAPLP00000005038, ENSAPLP00000004050, ENSAPLP00000014548, ENSAPLP00000002553, ENSAPLP00000003219, ENSAPLP00000000447 |
| regulation of biosynthetic process | ENSAPLP00000002553, ENSAPLP00000013416, ENSAPLP00000016219, ENSAPLP00000011529, ENSAPLP00000004050 |
| regulation of transcription, DNA-dependent | ENSAPLP00000002553, ENSAPLP00000013416, ENSAPLP00000016219 |
| cellular protein metabolic process | ENSAPLP00000009880, ENSAPLP00000008212, ENSAPLP00000003372, ENSAPLP00000010726, ENSAPLP00000014148, ENSAPLP00000014548, ENSAPLP00000015793 |
| regulation of RNA biosynthetic process | ENSAPLP00000002553, ENSAPLP00000013416, ENSAPLP00000016219 |
| regulation of macromolecule metabolic process | ENSAPLP00000002553, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000016219, ENSAPLP00000005038, ENSAPLP00000004050 |
| regulation of macromolecule biosynthetic process | ENSAPLP00000002553, ENSAPLP00000013416, ENSAPLP00000016219, ENSAPLP00000004050 |
| regulation of cellular biosynthetic process | ENSAPLP00000002553, ENSAPLP00000013416, ENSAPLP00000016219, ENSAPLP00000004050 |
| regulation of RNA metabolic process | ENSAPLP00000002553, ENSAPLP00000013416, ENSAPLP00000016219 |
| regulation of nucleobase-containing compound metabolic process | ENSAPLP00000002553, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000016219 |
| regulation of nitrogen compound metabolic process | ENSAPLP00000002553, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000016219 |
| regulation of cellular macromolecule biosynthetic process | ENSAPLP00000002553, ENSAPLP00000013416, ENSAPLP00000016219 |
| regulation of gene expression | ENSAPLP00000002553, ENSAPLP00000013416, ENSAPLP00000016219, ENSAPLP00000005038 |
|